1.

Trastuzumab deruxtecan versus treatment of physician’s choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial.

André F, Hee Park Y, Kim SB, Takano T, Im SA, Borges G, Lima JP, Aksoy S, Gavila Gregori J, De Laurentiis M, Bianchini G, Roylance R, Miyoshi Y, Armstrong A, Sinha R, Ruiz Borrego M, Lim E, Ettl J, Yerushalmi R, Zagouri F, Duhoux FP, Fehm T, Gambhire D, Cathcart J, Wu C, Chu C, Egorov A, Krop I.

Lancet. 2023 May 27;401(10390):1773-1785. doi: 10.1016/S0140-6736(23)00725-0. Epub 2023 Apr 20.

PMID: 37086745 Clinical Trial.

2.

Prolonged impact of anti-cancer therapy on endothelial function and arterial stiffness in breast cancer patients.

Anastasiou M, Oikonomou E, Theofilis P, Papamikroulis GA, Gazouli M, Kalogeras K, Lygkoni S, Pesiridis T, Goliopoulou A, Papatheodoridi A, Psyrri A, Zagouri F, Siasos G, Tousoulis D.

Vascul Pharmacol. 2023 Oct;152:107195. doi: 10.1016/j.vph.2023.107195. Epub 2023 Jul 15.

PMID: 37455009

3.

Defining Oligometastatic Bladder Cancer: A Systematic Review.

Bamias A, Stenzl A, Zagouri F, Andrikopoulou A, Hoskin P.

Eur Urol Open Sci. 2023 Aug 22;55:28-37. doi: 10.1016/j.euros.2023.08.003. eCollection 2023 Sep.

PMID: 37662704 Free PMC article. Review.

4.

Optimal Time Interval between Neoadjuvant Platinum-Based Chemotherapy and Interval Debulking Surgery in High-Grade Serous Ovarian Cancer.

Andrikopoulou A, Theofanakis C, Markellos C, Kaparelou M, Koutsoukos K, Apostolidou K, Thomakos N, Haidopoulos D, Rodolakis A, Dimopoulos MA, Zagouri F, Liontos M.

Cancers (Basel). 2023 Jul 6;15(13):3519. doi: 10.3390/cancers15133519.

PMID: 37444629 Free PMC article.

5.

Intravenous rituximab and oral cyclophosphamide for the treatment of cancer‑associated retinopathy in a patient with epithelial ovarian cancer: A case report.

Andrikopoulou A, Koutsoukos K, Chatziralli I, Theodossiadis P, Tsivgoulis G, Tzartos J, Anastasakis A, Zagouri F, Dimopoulos MA.

Oncol Lett. 2023 Jun 1;26(1):308. doi: 10.3892/ol.2023.13894. eCollection 2023 Jul.

PMID: 37332336 Free PMC article.

6.

Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting.

Skafida E, Andrikopoulou A, Terpos E, Markellos C, Moustafa S, Pectasides D, Dimopoulos MA, Zagouri F, Vassilopoulos D.

Breast J. 2023 May 31;2023:3614296. doi: 10.1155/2023/3614296. eCollection 2023.

PMID: 37293258 Free PMC article. Review.

7.

Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.

Hadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ; LIBRETTO-531 Trial Investigators.

N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21.

PMID: 37870969 Clinical Trial.

8.

Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature.

Papatheodoridi A, Papamattheou E, Marinopoulos S, Ntanasis-Stathopoulos I, Dimitrakakis C, Giannos A, Kaparelou M, Liontos M, Dimopoulos MA, Zagouri F.

Med Sci (Basel). 2023 May 19;11(2):35. doi: 10.3390/medsci11020035.

PMID: 37218987 Free PMC article. Review.

9.

Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer.

Andrikopoulou A, Liontos M, Skafida E, Koutsoukos K, Apostolidou K, Kaparelou M, Rouvalis A, Bletsa G, Dimopoulos MA, Zagouri F.

Int J Gynecol Cancer. 2023 Apr 3;33(4):571-576. doi: 10.1136/ijgc-2022-003941.

PMID: 36604119

10.

What to expect from paraneoplastic syndromes of the nervous system in uterine cancer: A review of the literature.

Svarna A, Liontos M, Reppas G, Fiste O, Andrikopoulou A, Dimopoulos MA, Zagouri F.

Gynecol Oncol Rep. 2023 Jan 16;45:101136. doi: 10.1016/j.gore.2023.101136. eCollection 2023 Feb.

PMID: 36703705 Free PMC article. Review.

11.

Mutation Profile of HPV16 L1 and L2 Genes in Different Geographic Areas.

Tsakogiannis D, Nikolaidis M, Zagouri F, Zografos E, Kottaridi C, Kyriakopoulou Z, Tzioga L, Markoulatos P, Amoutzias GD, Bletsa G.

Viruses. 2022 Dec 31;15(1):141. doi: 10.3390/v15010141.

PMID: 36680181 Free PMC article. Review.

12.

Baseline Ang-2 Serum Levels as a Predictive Factor for Survival in NSCLC and SCLC.

Nikolakopoulou A, Tsakogiannis D, Zagouri F, Zografos E, Tzioga L, Stratakos G, Koulouris N, Syrigos K, Bletsa G.

Life (Basel). 2022 Dec 13;12(12):2092. doi: 10.3390/life12122092.

PMID: 36556457 Free PMC article.

13.

Germline and somatic variants in ovarian carcinoma: A next-generation sequencing (NGS) analysis.

Andrikopoulou A, Zografos E, Apostolidou K, Kyriazoglou A, Papatheodoridi AM, Kaparelou M, Koutsoukos K, Liontos M, Dimopoulos MA, Zagouri F.

Front Oncol. 2022 Dec 1;12:1030786. doi: 10.3389/fonc.2022.1030786. eCollection 2022.

PMID: 36531003 Free PMC article.

14.

Genetic Predisposition to Male Breast Cancer: A Case Series.

Apessos A, Agiannitopoulos K, Pepe G, Tsaousis GN, Pitta P, Bili C, Florentin L, Saloustros E, Kampletsas E, Tryfonopoulos D, Tsoukalas N, Bournakis E, Zagouri F, Kotsakis A, Koumarianou A, Korantzis I, Boukovinas I, Lypas G, Fountzilas G, Michalaki V, Xynogalos S, Linardou H, Papadopoulou E, Nasioulas G, Georgoulias V.

Anticancer Res. 2022 Dec;42(12):5795-5801. doi: 10.21873/anticanres.16086.

PMID: 36456130

15.

Subarachnoid hemorrhage in a postpartum mother: A rare manifestation of an uncommon disease.

Fiste O, Mavrothalassitis E, Markellos C, Rodolakis A, Zagouri F, Dimopoulos MA, Liontos M.

Gynecol Oncol Rep. 2022 Oct 25;44:101092. doi: 10.1016/j.gore.2022.101092. eCollection 2022 Dec.

PMID: 36325115 Free PMC article.

16.

Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy-A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study.

Spathas N, Goussia AC, Koliou GA, Gogas H, Zagouri F, Batistatou A, Charchanti AV, Papoudou-Bai A, Bobos M, Chrisafi S, Chatzopoulos K, Kostopoulos I, Koletsa T, Arapantoni P, Pectasides D, Galani E, Koutras A, Zarkavelis G, Saloustros E, Bafaloukos D, Karanikiotis C, Bompolaki I, Aravantinos G, Psyrri A, Razis E, Koumarianou A, Res E, Linardou H, Fountzilas G.

Cancers (Basel). 2022 Nov 16;14(22):5635. doi: 10.3390/cancers14225635.

PMID: 36428728 Free PMC article.

17.

Chasing Hippos: Implications of YAP1 and TAZ Expression in Pregnancy-associated Breast Cancer Tumorigenesis.

Kyriazoglou A, Korakiti AM, Papatheodoridi AM, Apostolidou K, Nonni A, Zografos E, Bletsa G, Tsakogiannis D, Dimopoulos MA, Zagouri F.

In Vivo. 2022 Nov-Dec;36(6):2869-2874. doi: 10.21873/invivo.13027.

PMID: 36309401 Free PMC article.

18.

Machine learning applications in gynecological cancer: A critical review.

Fiste O, Liontos M, Zagouri F, Stamatakos G, Dimopoulos MA.

Crit Rev Oncol Hematol. 2022 Nov;179:103808. doi: 10.1016/j.critrevonc.2022.103808. Epub 2022 Sep 7.

PMID: 36087852 Review.

19.

PD-L1 Gene Polymorphisms rs822336 G>C and rs822337 T>A: Promising Prognostic Markers in Triple Negative Breast Cancer Patients.

Makrantonakis AE, Zografos E, Gazouli M, Dimitrakakis K, Toutouzas KG, Zografos CG, Kalapanida D, Tsiakou A, Samelis G, Zagouri F.

Medicina (Kaunas). 2022 Oct 6;58(10):1399. doi: 10.3390/medicina58101399.

PMID: 36295559 Free PMC article.

20.

Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents.

Zagouri F, Papatheodoridi A, Liontos M, Briasoulis A, Sklirou AD, Skafida E, Fiste O, Markellos C, Andrikopoulou A, Koutsoukos K, Kaparelou M, Gkogkou E, Trougakos IP, Dimopoulos MA, Terpos E.

Vaccines (Basel). 2022 Sep 5;10(9):1474. doi: 10.3390/vaccines10091474.

PMID: 36146552 Free PMC article.

21.

Real-world management patterns in EGFR-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece.

Lampaki S, Mountzios G, Georgoulias V, Rapti A, Xanthakis I, Baka S, Mavroudis D, Samantas E, Athanasiadis E, Zagouri F, Charpidou A, Somarakis A, Papista C, Nikolaou A, Anastasopoulou E, Paparepa Z, Syrigos KN.

Future Oncol. 2022 Sep;18(28):3151-3164. doi: 10.2217/fon-2022-0386. Epub 2022 Aug 5.

PMID: 35929414

22.

Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial.

Zagouri F, Koliou GA, Dimitrakopoulos F, Papadimitriou C, Binas I, Koutras A, Papakostas P, Markopoulos C, Venizelos V, Xepapadakis G, Andrikopoulou Α, Karanikiotis C, Psyrri A, Bafaloukos D, Kosmidis P, Aravantinos G, Res E, Mauri D, Koumarianou A, Petraki K, Tsipoura A, Pectasides D, Gogas H, Fountzilas G.

Br J Cancer. 2022 Sep;127(4):695-703. doi: 10.1038/s41416-022-01846-y. Epub 2022 May 24.

PMID: 35610366 Free PMC article. Clinical Trial.

23.

Multi-Gene Mutation Profiling by Targeted Next-Generation Sequencing in Premenopausal Breast Cancer.

Zografos E, Andrikopoulou A, Papatheodoridi AM, Kaparelou M, Bletsa G, Liontos M, Dimopoulos MA, Zagouri F.

Genes (Basel). 2022 Jul 29;13(8):1362. doi: 10.3390/genes13081362.

PMID: 36011273 Free PMC article.

24.

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators.

N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5.

PMID: 35665782 Free PMC article. Clinical Trial.

25.

SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition.

Terpos E, Liontos M, Fiste O, Zagouri F, Briasoulis A, Sklirou AD, Markellos C, Skafida E, Papatheodoridi A, Andrikopoulou A, Koutsoukos K, Kaparelou M, Iconomidou VA, Trougakos IP, Dimopoulos MA.

Cancers (Basel). 2022 Jun 4;14(11):2796. doi: 10.3390/cancers14112796.

PMID: 35681774 Free PMC article.

26.

“The emerging role of capivasertib in breast cancer”.

Andrikopoulou A, Chatzinikolaou S, Panourgias E, Kaparelou M, Liontos M, Dimopoulos MA, Zagouri F.

Breast. 2022 Jun;63:157-167. doi: 10.1016/j.breast.2022.03.018. Epub 2022 Apr 1.

PMID: 35398754 Free PMC article. Review.

27.

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study.

Rugo HS, O’Shaughnessy J, Boyle F, Toi M, Broom R, Blancas I, Gumus M, Yamashita T, Im YH, Rastogi P, Zagouri F, Song C, Campone M, San Antonio B, Shahir A, Hulstijn M, Brown J, Zimmermann A, Wei R, Johnston SRD, Reinisch M, Tolaney SM; monarchE Committee Members.

Ann Oncol. 2022 Jun;33(6):616-627. doi: 10.1016/j.annonc.2022.03.006. Epub 2022 Mar 23.

PMID: 35337972

28.

Advances in Gynecological Cancers.

Liontos M, Fiste O, Zagouri F, Dimopoulos MA.

Int J Mol Sci. 2022 May 31;23(11):6152. doi: 10.3390/ijms23116152.

PMID: 35682831 Free PMC article.

29.

Physical Exercise Restrains Cancer Progression through Muscle-Derived Factors.

Papadopetraki A, Maridaki M, Zagouri F, Dimopoulos MA, Koutsilieris M, Philippou A.

Cancers (Basel). 2022 Apr 8;14(8):1892. doi: 10.3390/cancers14081892.

PMID: 35454797 Free PMC article. Review.

30.

Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience.

Kaparelou M, Liontos M, Katsimbri P, Andrikopoulou A, Papatheodoridi A, Kyriazoglou A, Bamias A, Zagouri F, Dimopoulos MA.

Gynecol Oncol Rep. 2022 Mar 2;40:100953. doi: 10.1016/j.gore.2022.100953. eCollection 2022 Apr.

PMID: 35265745 Free PMC article.

31.

Oncological Patients With Endocrine Complications After Immunotherapy With Checkpoint Inhibitors Present Longer Progression-Free and Overall Survival.

Paschou SA, Liontos M, Eleftherakis-Papaiakovou E, Stefanaki K, Markellos C, Koutsoukos K, Zagouri F, Psaltopoulou T, Dimopoulos MA.

Front Oncol. 2022 Mar 24;12:847917. doi: 10.3389/fonc.2022.847917. eCollection 2022.

PMID: 35402216 Free PMC article.

32.

High-throughput Proteomic Profiling of Male Breast Cancer Tissue.

Zografos E, Proikakis SC, Anagnostopoulos AK, Korakiti AM, Zagouri F, Gazouli M, Tsangaris GT.

Cancer Genomics Proteomics. 2022 Mar-Apr;19(2):229-240. doi: 10.21873/cgp.20316.

PMID: 35181590 Free PMC article.

33.

Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients.

Liontos M, Terpos E, Kunadis E, Zagouri F, Briasoulis A, Skafida E, Fiste O, Markellos C, Andrikopoulou A, Gumeni S, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA.

Prostate Cancer Prostatic Dis. 2022 Mar;25(1):117-118. doi: 10.1038/s41391-021-00455-9. Epub 2021 Oct 9.

PMID: 34628475 Free PMC article.

34.

Survival with Cemiplimab in Recurrent Cervical Cancer.

Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, Kim YM, Lisyanskaya A, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin EA, Takahashi S, Ramone D, Pikiel J, Maćkowiak-Matejczyk B, Guerra Alía EM, Colombo N, Makarova Y, Rischin D, Lheureux S, Hasegawa K, Fujiwara K, Li J, Jamil S, Jankovic V, Chen CI, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Mathias M, Fury MG, Oaknin A; Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9.

N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187.

PMID: 35139273 Clinical Trial.

35.

Immunotherapy in HER2-Positive Breast Cancer: A Systematic Review.

Kyriazoglou A, Kaparelou M, Goumas G, Liontos M, Zakopoulou R, Zografos E, Zygogianni A, Dimopoulos MA, Zagouri F.

Breast Care (Basel). 2022 Feb;17(1):63-70. doi: 10.1159/000514860. Epub 2021 Mar 29.

PMID: 35355696 Free PMC article.

36.

Adjuvant Treatment of Elderly Breast Cancer Patients: Offer the Best Chances of Cure.

Marinopoulos S, Dimitrakakis C, Kalampalikis A, Zagouri F, Andrikopoulou A, Rodolakis A.

Breast Care (Basel). 2022 Feb;17(1):71-80. doi: 10.1159/000513708. Epub 2021 Mar 4.

PMID: 35355693 Free PMC article. Review.

37.

The Mutational Landscape of Early-Onset Breast Cancer: A Next-Generation Sequencing Analysis.

Andrikopoulou A, Chatzinikolaou S, Kyriopoulos I, Bletsa G, Kaparelou M, Liontos M, Dimopoulos MA, Zagouri F.

Front Oncol. 2022 Jan 21;11:797505. doi: 10.3389/fonc.2021.797505. eCollection 2021.

PMID: 35127508 Free PMC article.

38.

Correction to: Trastuzumab administration during pregnancy: an update.

Andrikopoulou A, Apostolidou K, Chatzinikolaou S, Bletsa G, Zografos E, Dimopoulos MA, Zagouri F.

BMC Cancer. 2021 Dec 17;21(1):1340. doi: 10.1186/s12885-021-09087-7.

PMID: 34920709 Free PMC article. No abstract available.

39.

Genetic variability of the HPV16 early genes and LCR. Present and future perspectives.

Bletsa G, Zagouri F, Amoutzias GD, Nikolaidis M, Zografos E, Markoulatos P, Tsakogiannis D.

Expert Rev Mol Med. 2021 Dec 1;23:e19. doi: 10.1017/erm.2021.18.

PMID: 34847982 Review.

40.

Pembrolizumab in endometrial cancer: Where we stand now.

Aravantinou-Fatorou A, Andrikopoulou A, Liontos M, Fiste O, Georgakopoulou VE, Dimopoulos MA, Gavriatopoulou M, Zagouri F.

Oncol Lett. 2021 Dec;22(6):821. doi: 10.3892/ol.2021.13082. Epub 2021 Oct 8.

PMID: 34691248 Free PMC article. Review.

41.

SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors.

Zagouri F, Terpos E, Fiste O, Liontos M, Briasoulis A, Katsiana I, Skafida E, Markellos C, Kunadis E, Andrikopoulou A, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA.

Breast. 2021 Dec;60:58-61. doi: 10.1016/j.breast.2021.08.017. Epub 2021 Aug 28.

PMID: 34481366 Free PMC article.

42.

What Has Changed in the Management of Uterine Serous Carcinomas? Two Decades of Experience.

Liontos M, Svarna A, Theofanakis C, Fiste O, Andrikopoulou A, Kaparelou M, Koutsoukos K, Thomakos N, Haidopoulos D, Rodolakis A, Dimopoulos MA, Zagouri F.

Curr Oncol. 2021 Nov 20;28(6):4862-4873. doi: 10.3390/curroncol28060410.

PMID: 34898589 Free PMC article.

43.

BRCA1/2 Mutation Types Do Not Affect Prognosis in Ovarian Cancer Patients.

Liontos M, Zografos E, Zoumpourlis P, Andrikopoulou A, Svarna A, Fiste O, Kunadis E, Papatheodoridi AM, Kaparelou M, Koutsoukos K, Thomakos N, Haidopoulos D, Rodolakis A, Dimopoulos MA, Zagouri F.

Curr Oncol. 2021 Nov 3;28(6):4446-4456. doi: 10.3390/curroncol28060377.

PMID: 34898566 Free PMC article.

44.

Update Overview of the Role of Angiopoietins in Lung Cancer.

Tsakogiannis D, Nikolakopoulou A, Zagouri F, Stratakos G, Syrigos K, Zografos E, Koulouris N, Bletsa G.

Medicina (Kaunas). 2021 Nov 1;57(11):1191. doi: 10.3390/medicina57111191.

PMID: 34833409 Free PMC article. Review.

45.

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy.

Liontos M, Andrikopoulou A, Koutsoukos K, Markellos C, Skafida E, Fiste O, Kaparelou M, Thomakos N, Haidopoulos D, Rodolakis A, Dimopoulos MA, Zagouri F.

J Ovarian Res. 2021 Nov 1;14(1):148. doi: 10.1186/s13048-021-00902-0.

PMID: 34724958 Free PMC article.

46.

TP53 mutations determined by targeted NGS in breast cancer: a case-control study.

Andrikopoulou A, Terpos E, Chatzinikolaou S, Apostolidou K, Ntanasis-Stathopoulos I, Gavriatopoulou M, Dimopoulos MA, Zagouri F.

Oncotarget. 2021 Oct 12;12(21):2206-2214. doi: 10.18632/oncotarget.28071. eCollection 2021 Oct 12.

PMID: 34676052 Free PMC article.

47.

Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors.

Liontos M, Terpos E, Markellos C, Zagouri F, Briasoulis A, Katsiana I, Skafida E, Fiste O, Kunadis E, Andrikopoulou A, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA.

Vaccines (Basel). 2021 Oct 8;9(10):1148. doi: 10.3390/vaccines9101148.

PMID: 34696256 Free PMC article.

48.

Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician’s choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33).

Musacchio L, Salutari V, Pignata S, Braicu E, Cibula D, Colombo N, Frenel JS, Zagouri F, Carbone V, Ghizzoni V, Giolitto S, Giudice E, Perri MT, Ricci C, Scambia G, Lorusso D.

Int J Gynecol Cancer. 2021 Oct;31(10):1369-1373. doi: 10.1136/ijgc-2021-002593.

PMID: 34607820 Clinical Trial.

49.

Immune checkpoint inhibitor administration during pregnancy: a case series.

Andrikopoulou A, Korakiti AM, Apostolidou K, Dimopoulos MA, Zagouri F.

ESMO Open. 2021 Oct;6(5):100262. doi: 10.1016/j.esmoop.2021.100262. Epub 2021 Sep 3.

PMID: 34487972 Free PMC article. Review.

50.

Occupational Exposure and Multiple Myeloma Risk: An Updated Review of Meta-Analyses.

Georgakopoulou R, Fiste O, Sergentanis TN, Andrikopoulou A, Zagouri F, Gavriatopoulou M, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA.

J Clin Med. 2021 Sep 16;10(18):4179. doi: 10.3390/jcm10184179.

PMID: 34575290 Free PMC article. Review.

51.

MicroRNAs as Potential Predictors of Response to CDK4/6 Inhibitor Treatment.

Andrikopoulou A, Shalit A, Zografos E, Koutsoukos K, Korakiti AM, Liontos M, Dimopoulos MA, Zagouri F.

Cancers (Basel). 2021 Aug 16;13(16):4114. doi: 10.3390/cancers13164114.

PMID: 34439268 Free PMC article. Review.

52.

Paraneoplastic cerebellar degeneration in platinum-responsive endometrial cancer: A case report and review of literature.

Liontos M, Fiste O, Drakopoulou D, Thomakos N, Goula K, Zagouri F, Anagnostouli M, Dimopoulos MA.

Gynecol Oncol Rep. 2021 Jun 29;37:100826. doi: 10.1016/j.gore.2021.100826. eCollection 2021 Aug.

PMID: 34258363 Free PMC article. Review.

53.

Cardiovascular toxicity of breast cancer treatment: an update.

Papageorgiou C, Andrikopoulou A, Dimopoulos MA, Zagouri F.

Cancer Chemother Pharmacol. 2021 Jul;88(1):15-24. doi: 10.1007/s00280-021-04254-w. Epub 2021 Apr 17.

PMID: 33864486 Review.

54.

CDK4/6 Inhibitors and Arthralgia: A Single Institution Experience.

Andrikopoulou A, Fiste O, Apostolidou K, Skafida E, Markellos C, Liontos M, Kyriazoglou A, Dimopoulos MA, Zagouri F.

Med Sci (Basel). 2021 Jun 5;9(2):42. doi: 10.3390/medsci9020042.

PMID: 34198899 Free PMC article.

55.

Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?

Fountzilas E, Kotoula V, Koliou GA, Liontos M, Papadopoulou K, Giannoulatou E, Papanikolaou A, Tikas I, Chrisafi S, Mauri D, Chatzopoulos K, Fostira F, Pectasides D, Oikonomopoulos G, Aivazi D, Andrikopoulou A, Visvikis A, Aravantinos G, Zagouri F, Fountzilas G.

Front Oncol. 2021 Jun 1;11:683057. doi: 10.3389/fonc.2021.683057. eCollection 2021.

PMID: 34141624 Free PMC article.

56.

Overweight/Obesity and Monoclonal Gammopathy of Undetermined Significance.

Georgakopoulou R, Andrikopoulou A, Sergentanis TN, Fiste O, Zagouri F, Gavriatopoulou M, Psaltopoulou T, Kastritis E, Terpos E, Dimopoulos MA.

Clin Lymphoma Myeloma Leuk. 2021 Jun;21(6):361-367. doi: 10.1016/j.clml.2021.01.008. Epub 2021 Jan 15.

PMID: 33582053 Review.

57.

Trastuzumab Deruxtecan (DS-8201a): The Latest Research and Advances in Breast Cancer.

Andrikopoulou A, Zografos E, Liontos M, Koutsoukos K, Dimopoulos MA, Zagouri F.

Clin Breast Cancer. 2021 Jun;21(3):e212-e219. doi: 10.1016/j.clbc.2020.08.006. Epub 2020 Aug 18.

PMID: 32917537 Review.

58.

Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors.

Terpos E, Zagouri F, Liontos M, Sklirou AD, Koutsoukos K, Markellos C, Briasoulis A, Papanagnou ED, Trougakos IP, Dimopoulos MA.

J Hematol Oncol. 2021 May 31;14(1):86. doi: 10.1186/s13045-021-01099-x.

PMID: 34059088 Free PMC article.

59.

Germline mutations in a clinic-based series of pregnancy associated breast cancer patients.

Zografos E, Korakiti AM, Andrikopoulou A, Rellias I, Dimitrakakis C, Marinopoulos S, Giannos A, Keramopoulos A, Bredakis N, Dimopoulos MA, Zagouri F.

BMC Cancer. 2021 May 19;21(1):572. doi: 10.1186/s12885-021-08310-9.

PMID: 34011307 Free PMC article.

60.

Trastuzumab administration during pregnancy: an update.

Andrikopoulou A, Apostolidou K, Chatzinikolaou S, Bletsa G, Zografos E, Dimopoulos MA, Zagouri F.

BMC Cancer. 2021 Apr 26;21(1):463. doi: 10.1186/s12885-021-08162-3.

PMID: 33902516 Free PMC article.

61.

The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma.

Fiste O, Ntanasis-Stathopoulos I, Gavriatopoulou M, Liontos M, Koutsoukos K, Dimopoulos MA, Zagouri F.

Vaccines (Basel). 2021 Apr 22;9(5):422. doi: 10.3390/vaccines9050422.

PMID: 33922362 Free PMC article. Review.

62.

Clinical perspectives of BET inhibition in ovarian cancer.

Andrikopoulou A, Liontos M, Koutsoukos K, Dimopoulos MA, Zagouri F.

Cell Oncol (Dordr). 2021 Apr;44(2):237-249. doi: 10.1007/s13402-020-00578-6. Epub 2021 Jan 19.

PMID: 33469840 Review.

63.

Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting.

Liontos M, Papatheodoridi A, Andrikopoulou A, Thomakos N, Haidopoulos D, Rodolakis A, Zagouri F, Bamias A, Dimopoulos MA.

Curr Oncol. 2021 Mar 7;28(2):1143-1152. doi: 10.3390/curroncol28020110.

PMID: 33800101 Free PMC article.

64.

Androgen Receptor and PIM1 Expression in Tumor Tissue of Patients With Triple-negative Breast Cancer.

Ntzifa A, Strati A, Koliou GA, Zagouri F, Pectasides D, Pentheroudakis G, Christodoulou C, Gogas H, Magkou C, Petraki C, Kosmidis P, Aravantinos G, Kotoula V, Fountzilas G, Lianidou E.

Cancer Genomics Proteomics. 2021 Mar-Apr;18(2):147-156. doi: 10.21873/cgp.20249.

PMID: 33608311 Free PMC article. Review.

65.

Vascular Inflammation and Cardiovascular Burden in Metastatic Breast Cancer Female Patients Receiving Hormonal Treatment and CDK 4/6 Inhibitors or Everolimus.

Papageorgiou C, Zagouri F, Tampakis K, Georgakopoulou R, Manios E, Kafouris P, Benetos G, Koutagiar I, Anagnostopoulos C, Dimopoulos MA, Toutouzas K.

Front Cardiovasc Med. 2021 Feb 23;8:638895. doi: 10.3389/fcvm.2021.638895. eCollection 2021.

PMID: 33732735 Free PMC article.

66.

Continuing Cancer Therapy through the Pandemic While Protecting Our Patients: Results of the Implementation of Preventive Strategies in a Referral Oncology Unit.

Liontos M, Kastritis E, Markellos C, Migkou M, Eleftherakis-Papaiakovou E, Koutsoukos K, Gavriatopoulou M, Zagouri F, Psaltopoulou T, Terpos E, Dimopoulos MA.

Cancers (Basel). 2021 Feb 12;13(4):763. doi: 10.3390/cancers13040763.

PMID: 33673120 Free PMC article.

67.

The Role of the Hippo Pathway in Breast Cancer Carcinogenesis, Prognosis, and Treatment: A Systematic Review.

Kyriazoglou A, Liontos M, Zakopoulou R, Kaparelou M, Tsiara A, Papatheodoridi AM, Georgakopoulou R, Zagouri F.

Breast Care (Basel). 2021 Feb;16(1):6-15. doi: 10.1159/000507538. Epub 2020 May 12.

PMID: 33716627 Free PMC article. Review.

68.

How we treat endocrine complications of immune checkpoint inhibitors.

Paschou SA, Stefanaki K, Psaltopoulou T, Liontos M, Koutsoukos K, Zagouri F, Lambrinoudaki I, Dimopoulos MA.

ESMO Open. 2021 Feb;6(1):100011. doi: 10.1016/j.esmoop.2020.100011. Epub 2021 Jan 4.

PMID: 33399077 Free PMC article. Review.

69.

Determination of FABP4, RBP4 and the MMP-9/NGAL complex in the serum of women with breast cancer.

Tsakogiannis D, Kalogera E, Zagouri F, Zografos E, Balalis D, Bletsa G.

Oncol Lett. 2021 Feb;21(2):85. doi: 10.3892/ol.2020.12346. Epub 2020 Dec 4.

PMID: 33376518 Free PMC article.

70.

Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review.

Andrikopoulou A, Fiste O, Liontos M, Dimopoulos MA, Zagouri F.

Cancers (Basel). 2021 Jan 26;13(3):465. doi: 10.3390/cancers13030465.

PMID: 33530456 Free PMC article. Review.

71.

Long-Term Neurodevelopmental Outcome of Children after in Utero Exposure to Chemotherapy.

Korakiti AM, Zografos E, van Gerwen M, Amant F, Dimopoulos MA, Zagouri F.

Cancers (Basel). 2020 Dec 3;12(12):3623. doi: 10.3390/cancers12123623.

PMID: 33287323 Free PMC article. Review.

72.

Circulating tumor DNA-based predictive biomarkers in breast cancer clinical trials: a narrative review.

Fiste O, Liontos M, Koutsoukos K, Terpos E, Dimopoulos MA, Zagouri F.

Ann Transl Med. 2020 Dec;8(23):1603. doi: 10.21037/atm-20-1175.

PMID: 33437802 Free PMC article. Review.

73.

Supportive medication in cancer during pregnancy.

Zagouri F, Dedes N, Papatheodoridi A, Liontos M, Dimopoulos MA.

BMC Pregnancy Childbirth. 2020 Dec 1;20(1):747. doi: 10.1186/s12884-020-03432-7.

PMID: 33261562 Free PMC article. Review.

74.

Response of an oncology unit in the midst of the COVID-19 outbreak.

Liontos M, Kastritis E, Migkou M, Koutsoukos K, Eleutherakis-Papaiakovou E, Gavriatopoulou M, Psaltopoulou T, Zagouri F, Terpos E, Dimopoulos MA.

J Oncol Pharm Pract. 2020 Dec;26(8):1947-1952. doi: 10.1177/1078155220967973. Epub 2020 Oct 22.

PMID: 33092498

75.

Clinical Perspectives of ERCC1 in Bladder Cancer.

Koutsoukos K, Andrikopoulou A, Dedes N, Zagouri F, Bamias A, Dimopoulos MA.

Int J Mol Sci. 2020 Nov 22;21(22):8829. doi: 10.3390/ijms21228829.

PMID: 33266377 Free PMC article. Review.

76.

The emerging role of BET inhibitors in breast cancer.

Andrikopoulou A, Liontos M, Koutsoukos K, Dimopoulos MA, Zagouri F.

Breast. 2020 Oct;53:152-163. doi: 10.1016/j.breast.2020.08.005. Epub 2020 Aug 13.

PMID: 32827765 Free PMC article. Review.

77.

The Genomic Profile of Pregnancy-Associated Breast Cancer: A Systematic Review.

Korakiti AM, Moutafi M, Zografos E, Dimopoulos MA, Zagouri F.

Front Oncol. 2020 Sep 11;10:1773. doi: 10.3389/fonc.2020.01773. eCollection 2020.

PMID: 33014874 Free PMC article.

78.

A Case Series of BCOR Sarcomas With a New Splice Variant of BCOR/CCNB3 Fusion Gene.

Kyriazoglou A, Tourkantoni N, Liontos M, Zagouri F, Mahaira L, Papakosta A, Michali D, Patereli A, Stefanaki K, Tzotzola V, Skoura E, Baka M, Polychronopoulou S, Kattamis A, Dimitriadis E.

In Vivo. 2020 Sep-Oct;34(5):2947-2954. doi: 10.21873/invivo.12125.

PMID: 32871837 Free PMC article.

79.

Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group.

Fountzilas E, Koliou GA, Vozikis A, Rapti V, Nikolakopoulos A, Boutis A, Christopoulou A, Kontogiorgos I, Karageorgopoulou S, Lalla E, Tryfonopoulos D, Boukovinas I, Rapti C, Nikolaidi A, Karteri S, Moirogiorgou E, Binas I, Mauri D, Aravantinos G, Zagouri F, Saridaki Z, Psyrri A, Bafaloukos D, Koumarianou A, Res E, Linardou H, Mountzios G, Razis E, Fountzilas G, Koumakis G.

ESMO Open. 2020 Aug;5(4):e000774. doi: 10.1136/esmoopen-2020-000774.

PMID: 32817060 Free PMC article.

80.

Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19.

Liontos M, Kaparelou M, Karofylakis E, Kavatha D, Mentis A, Zagouri F, Terpos E, Dimopoulos MA.

Gynecol Oncol Rep. 2020 Jul 30;33:100615. doi: 10.1016/j.gore.2020.100615. eCollection 2020 Aug.

PMID: 32766415 Free PMC article.

81.

Intrathecal administration of anti-HER2 treatment for the treatment of meningeal carcinomatosis in breast cancer: A metanalysis with meta-regression.

Zagouri F, Zoumpourlis P, Le Rhun E, Bartsch R, Zografos E, Apostolidou K, Dimopoulos MA, Preusser M.

Cancer Treat Rev. 2020 Aug;88:102046. doi: 10.1016/j.ctrv.2020.102046. Epub 2020 Jun 3.

PMID: 32599393

82.

Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) Trial.

Koutras A, Zagouri F, Koliou GA, Psoma E, Chryssogonidis I, Lazaridis G, Tryfonopoulos D, Kotsakis A, Res E, Kentepozidis NK, Razis E, Psyrri A, Koumakis G, Kalofonos HP, Dimopoulos MA, Fountzilas G.

Br J Cancer. 2020 Aug;123(3):355-361. doi: 10.1038/s41416-020-0909-4. Epub 2020 Jun 3.

PMID: 32488135 Free PMC article. Clinical Trial.

83.

Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?

Koletsa T, Kotoula V, Koliou GA, Manousou K, Chrisafi S, Zagouri F, Sotiropoulou M, Pentheroudakis G, Papoudou-Bai A, Christodoulou C, Xepapadakis G, Zografos G, Petraki K, Pazarli E, Koutras A, Kourea HP, Bafaloukos D, Chatzopoulos K, Iliadis A, Markopoulos C, Venizelos V, Arnogiannaki N, Kalogeras KT, Kostopoulos I, Gogas H, Fountzilas G.

Cancer Immunol Immunother. 2020 Aug;69(8):1549-1564. doi: 10.1007/s00262-020-02557-0. Epub 2020 Apr 18.

PMID: 32303794

84.

ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer.

Koumarianou A, Makrantonakis P, Zagouri F, Papadimitriou C, Christopoulou A, Samantas E, Christodoulou C, Psyrri A, Bafaloukos D, Aravantinos G, Papakotoulas P, Baka S, Andreadis C, Alexopoulos A, Bompolaki I, Kampoli Κ, Liori S, Karvounis K, Ardavanis A.

Breast Cancer Res Treat. 2020 Jul;182(1):85-96. doi: 10.1007/s10549-020-05677-4. Epub 2020 May 16.

PMID: 32418045

85.

Carotid Disease and Ageing: A Literature Review on the Pathogenesis of Vascular Senescence in Older Subjects.

Sertedaki E, Veroutis D, Zagouri F, Galyfos G, Filis K, Papalambros A, Aggeli K, Tsioli P, Charalambous G, Zografos G, Sigala F.

Curr Gerontol Geriatr Res. 2020 Jun 13;2020:8601762. doi: 10.1155/2020/8601762. eCollection 2020.

PMID: 32582337 Free PMC article. Review.

86.

Secondary Alopecia Neoplastica Mimicking Alopecia Areata following Breast Cancer.

Skafida E, Triantafyllopoulou I, Flessas I, Liontos M, Koutsoukos K, Zagouri F, Dimopoulos AM.

Case Rep Oncol. 2020 Jun 11;13(2):627-632. doi: 10.1159/000507694. eCollection 2020 May-Aug.

PMID: 32774247 Free PMC article.

87.

Axitinib as a third or further line of treatment in renal cancer: a single institution experience.

Tsironis G, Liontos M, Kyriazoglou A, Koutsoukos K, Tsiara A, Kaparelou M, Zakopoulou R, Cohen A, Skafida E, Fontara S, Zagouri F, Bamias A, Dimopoulos MA.

BMC Urol. 2020 Jun 2;20(1):60. doi: 10.1186/s12894-020-00618-1.

PMID: 32487200 Free PMC article.

88.

Lymphocytic infiltration and Chemotherapy Response Score as prognostic markers in ovarian cancer patients treated with Neoadjuvant chemotherapy.

Liontos M, Sotiropoulou M, Kaparelou M, Tzannis K, Tsironis G, Kyriazoglou A, Tsiara A, Zakopoulou R, Koutsoukos K, Zagouri F, Thomakos N, Haidopoulos D, Rodolakis A, Dimopoulos MA, Bamias A.

Gynecol Oncol. 2020 Jun;157(3):599-605. doi: 10.1016/j.ygyno.2020.03.008. Epub 2020 Mar 12.

PMID: 32173048

89.

The learning curve of breast lesion excision system: Balancing patient’s safety and surgical training.

Maniou I, Kontos M, Kontzoglou K, Pagkalos I, Zografos CG, Zagouri F, Zografos GC.

Breast J. 2020 Apr;26(4):803-805. doi: 10.1111/tbj.13632. Epub 2019 Dec 16.

PMID: 31845446 No abstract available.

90.

Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Elderly Patients With Breast Cancer.

Nikolaidi A, Kotoula V, Koliou GA, Giannoulatou E, Papadopoulou K, Zagouri F, Pentheroudakis G, Gogas H, Bobos M, Chatzopoulos K, Oikonomopoulos G, Pectasides D, Saloustros E, Arnogiannaki N, Nicolaou I, Papakostas P, Bompolaki I, Aravantinos G, Athanasiadis I, Fountzilas G.

Cancer Genomics Proteomics. 2020 Mar-Apr;17(2):181-193. doi: 10.21873/cgp.20179.

PMID: 32108041 Free PMC article.

91.

Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?

Kyriazoglou A, Koutsoukos K, Zagouri F, Liontos M, Dimitriadis E, Tiniakos D, Dimopoulos MA.

Ther Clin Risk Manag. 2020 Feb 27;16:141-146. doi: 10.2147/TCRM.S220804. eCollection 2020.

PMID: 32161464 Free PMC article.

92.

First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study.

Sgouros J, Aravantinos G, Koliou GA, Pentheroudakis G, Zagouri F, Psyrri A, Lampropoulou DI, Demiri S, Pectasides D, Razis E, Fountzilas G, Samantas E.

Anticancer Res. 2020 Feb;40(2):929-938. doi: 10.21873/anticanres.14026.

PMID: 32014937 Clinical Trial.

93.

The Role of CXCL13 and CXCL9 in Early Breast Cancer.

Razis E, Kalogeras KT, Kotsantis I, Koliou GA, Manousou K, Wirtz R, Veltrup E, Patsea H, Poulakaki N, Dionysopoulos D, Pervana S, Gogas H, Koutras A, Pentheroudakis G, Christodoulou C, Linardou H, Pavlakis K, Koletsa T, Pectasides D, Zagouri F, Fountzilas G.

Clin Breast Cancer. 2020 Feb;20(1):e36-e53. doi: 10.1016/j.clbc.2019.08.008. Epub 2019 Sep 5.

PMID: 31699671

94.

Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative.

Fountzilas E, Kotoula V, Koliou GA, Giannoulatou E, Gogas H, Papadimitriou C, Tikas I, Zhang J, Papadopoulou K, Zagouri F, Christodoulou C, Koutras A, Makatsoris T, Chrisafi S, Linardou H, Varthalitis I, Papatsibas G, Razis E, Papakostas P, Samantas E, Aravantinos G, Bafaloukos D, Kosmidis P, Koumarianou A, Psyrri A, Pentheroudakis G, Pectasides D, Futreal A, Fountzilas G, Tsimberidou AM.

Oncotarget. 2020 Jan 7;11(1):1-14. doi: 10.18632/oncotarget.27338. eCollection 2020 Jan 7.

PMID: 32002119 Free PMC article.

95.

Prognostic role of microRNAs in breast cancer: A systematic review.

Zografos E, Zagouri F, Kalapanida D, Zakopoulou R, Kyriazoglou A, Apostolidou K, Gazouli M, Dimopoulos MA.

Oncotarget. 2019 Dec 24;10(67):7156-7178. doi: 10.18632/oncotarget.27327. eCollection 2019 Dec 24.

PMID: 31903173 Free PMC article.

96.

Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting.

Amant F, Berveiller P, Boere IA, Cardonick E, Fruscio R, Fumagalli M, Halaska MJ, Hasenburg A, Johansson ALV, Lambertini M, Lok CAR, Maggen C, Morice P, Peccatori F, Poortmans P, Van Calsteren K, Vandenbroucke T, van Gerwen M, van den Heuvel-Eibrink M, Zagouri F, Zapardiel I.

Ann Oncol. 2019 Oct 1;30(10):1601-1612. doi: 10.1093/annonc/mdz228.

PMID: 31435648 Review.

97.

Taxanes during pregnancy in cervical cancer: A systematic review and pooled analysis.

Zagouri F, Korakiti AM, Zakopoulou R, Kyriazoglou A, Zografos E, Haidopoulos D, Apostolidou K, Papatheodoridi MA, Dimopoulos MA.

Cancer Treat Rev. 2019 Sep;79:101885. doi: 10.1016/j.ctrv.2019.08.001. Epub 2019 Aug 6.

PMID: 31442939

98.

Discrepancies of current recommendations in breast cancer follow-up: a systematic review.

Kyriazoglou A, Zagouri F, Fotiou D, Dimitrakakis C, Marinopoulos S, Zakopoulou R, Kaparelou M, Zygogianni A, Dimopoulos MA.

Breast Cancer. 2019 Sep;26(5):681-686. doi: 10.1007/s12282-019-00963-6. Epub 2019 Mar 18.

PMID: 30887287

99.

Vinflunine in the treatment of relapsed metastatic urothelial cancer: A systematic review and meta-analysis of real-world series.

Bamias A, Hegele A, Medioni J, Castellano D, Doni L, Passalacqua R, Zagouri F, Tzannis K, Hussain S, Ullen A.

Crit Rev Oncol Hematol. 2019 Aug;140:80-87. doi: 10.1016/j.critrevonc.2019.05.006. Epub 2019 May 21.

PMID: 31133463

100.

Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma.

Terpos E, Katodritou E, Symeonidis A, Zagouri F, Gerofotis A, Christopoulou G, Gavriatopoulou M, Christoulas D, Ntanasis-Stathopoulos I, Kourakli A, Konstantinidou P, Kastritis E, Dimopoulos MA.

Int J Cancer. 2019 Jul 15;145(2):559-568. doi: 10.1002/ijc.32125. Epub 2019 Jan 22.

PMID: 30650184 Clinical Trial.

101.

Paving the way for changing perceptions in breast surgery: a systematic literature review focused on oncological and aesthetic outcomes of oncoplastic surgery for breast cancer.

Papanikolaou IG, Dimitrakakis C, Zagouri F, Marinopoulos S, Giannos A, Zografos E, Zografos CG, Kritikou D, Rodolakis A, Zografos GC, Loutradis D.

Breast Cancer. 2019 Jul;26(4):416-427. doi: 10.1007/s12282-019-00968-1. Epub 2019 Apr 6.

PMID: 30955172

102.

Olaratumab administered in two cases of phyllodes tumour of the breast: end of the beginning?

Kyriazoglou A, Zagouri F, Dimopoulos MA.

ESMO Open. 2019 Jun 25;4(3):e000479. doi: 10.1136/esmoopen-2018-000479. eCollection 2019.

PMID: 31321082 Free PMC article.

103.

Prognostic significance of miR-34 rs4938723 T > C polymorphism in triple negative breast cancer patients.

Tsiakou A, Zagouri F, Zografos E, Samelis G, Gazouli M, Kalapanida D, Giannos A, Marinopoulos S, Dimitrakakis K, Lazaris C A, Rigopoulos D, Zografos G.

Clin Biochem. 2019 Jun;68:9-14. doi: 10.1016/j.clinbiochem.2019.03.009. Epub 2019 Mar 29.

PMID: 30935968

104.

Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case-control study.

Kalapanida D, Zagouri F, Gazouli M, Tsiakou A, Zografos E, Dimitrakakis C, Marinopoulos S, Giannos A, Sergentanis TN, Kastritis E, Terpos E, Dimopoulos MA.

Onco Targets Ther. 2019 May 28;12:4195-4202. doi: 10.2147/OTT.S189329. eCollection 2019.

PMID: 31213837 Free PMC article.

105.

Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer.

Lazaridis G, Kotoula V, Vrettou E, Kostopoulos I, Manousou K, Papadopoulou K, Giannoulatou E, Bobos M, Sotiropoulou M, Pentheroudakis G, Efstratiou I, Papoudou-Bai A, Psyrri A, Christodoulou C, Gogas H, Koutras A, Timotheadou E, Pectasides D, Zagouri F, Fountzilas G.

Cancer Genomics Proteomics. 2019 May-Jun;16(3):195-206. doi: 10.21873/cgp.20125.

PMID: 31018950 Free PMC article.

106.

The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study.

Bamias A, Karavasilis V, Gavalas N, Tzannis K, Samantas E, Aravantinos G, Koutras A, Gkerzelis I, Kostouros E, Koutsoukos K, Zagouri F, Fountzilas G, Dimopoulos MA.

Int J Clin Oncol. 2019 Apr;24(4):411-419. doi: 10.1007/s10147-018-1361-9. Epub 2018 Oct 29.

PMID: 30374686 Clinical Trial.

107.

Serum Proteomic Signatures of Male Breast Cancer.

Zografos E, Anagnostopoulos AK, Papadopoulou A, Legaki E, Zagouri F, Marinos E, Tsangaris GT, Gazouli M.

Cancer Genomics Proteomics. 2019 Mar-Apr;16(2):129-137. doi: 10.21873/cgp.20118.

PMID: 30850364 Free PMC article.

108.

Management of advanced prostate cancer: A systematic review of existing guidelines and recommendations.

Dellis A, Zagouri F, Liontos M, Mitropoulos D, Bamias A, Papatsoris AG; Hellenic Genito-Urinary Cancer Group (HCUCG).

Cancer Treat Rev. 2019 Feb;73:54-61. doi: 10.1016/j.ctrv.2018.11.005. Epub 2018 Dec 1.

PMID: 30623865

109.

Management of uterine sarcomas and prognostic indicators: real world data from a single-institution.

Kyriazoglou A, Liontos M, Ziogas DC, Zagouri F, Koutsoukos K, Tsironis G, Tsiara A, Kaparelou M, Zakopoulou R, Thomakos N, Haidopoulos D, Papaspyrou I, Rodolakis A, Bamias A, Dimopoulos MA.

BMC Cancer. 2018 Dec 13;18(1):1247. doi: 10.1186/s12885-018-5156-1.

PMID: 30541504 Free PMC article.

110.

Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study.

Kalapanida D, Zagouri F, Gazouli M, Zografos E, Dimitrakakis C, Marinopoulos S, Giannos A, Sergentanis TN, Kastritis E, Terpos E, Dimopoulos MA.

Oncotarget. 2018 Dec 11;9(97):36906-36913. doi: 10.18632/oncotarget.26385. eCollection 2018 Dec 11.

PMID: 30651924 Free PMC article.

111.

Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy.

Tsiatas M, Kalogeras KT, Manousou K, Wirtz RM, Gogas H, Veltrup E, Zagouri F, Lazaridis G, Koutras A, Christodoulou C, Pentheroudakis G, Petraki C, Bafaloukos D, Pectasides D, Kosmidis P, Samantas E, Karanikiotis C, Papakostas P, Dimopoulos MA, Fountzilas G.

Cancer Med. 2018 Oct;7(10):5066-5082. doi: 10.1002/cam4.1730. Epub 2018 Sep 21.

PMID: 30240146 Free PMC article. Clinical Trial.

112.

Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.

Goussia A, Simou N, Zagouri F, Manousou K, Lazaridis G, Gogas H, Koutras A, Sotiropoulou M, Pentheroudakis G, Bafaloukos D, Markopoulos C, Patsea H, Christodoulou C, Papakostas P, Zaramboukas T, Samantas E, Kosmidis P, Venizelos V, Karanikiotis C, Papatsibas G, Xepapadakis G, Kalogeras KT, Bamia C, Dimopoulos MA, Malamou-Mitsi V, Fountzilas G, Batistatou A.

PLoS One. 2018 Jul 31;13(7):e0200302. doi: 10.1371/journal.pone.0200302. eCollection 2018.

PMID: 30063723 Free PMC article. Clinical Trial.

113.

Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.

Batistatou A, Kotoula V, Bobos M, Kouvatseas G, Zagouri F, Tsolaki E, Gogas H, Koutras A, Pentheroudakis G, Timotheadou E, Pervana S, Goussia A, Petraki K, Sotiropoulou M, Koletsa T, Razis E, Kosmidis P, Aravantinos G, Papadimitriou C, Pectasides D, Fountzilas G.

Clin Breast Cancer. 2018 Feb;18(1):53-62.e3. doi: 10.1016/j.clbc.2017.07.004. Epub 2017 Jul 13.

PMID: 28870680 Clinical Trial.

114.

Flow-Mediated Dilation of Brachial Artery as a Screening Tool for Anthracycline-Induced Cardiotoxicity.

Anastasiou M, Oikonomou E, Zagouri F, Siasos G, Antonopoulos AS, Psaltopoulou T, Bamias A, Dimopoulos MA, Tousoulis D.

J Am Coll Cardiol. 2017 Dec 19;70(24):3072. doi: 10.1016/j.jacc.2017.09.1140.

PMID: 29241496 No abstract available.

115.

Stage-II thymoma and emergency coronary artery bypass. To irradiate or not to irradiate to avoid radiation induced vascular injury? Case report and literature review.

Kouerinis IA, Tolia M, Zagouri F, Nikolaou M, Tsoukalas N, Kyrgias G, Dimopoulos MA, Vlachopoulos C, Karathanassis I, Zoubouli CK, Kokakis I, Kouloulias V, Triantafillou K.

J BUON. 2017 Nov-Dec;22(6):1385-1389.

PMID: 29332327 Review.

116.

Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.

Zagouri F, Kastritis E, Zomas A, Terpos E, Katodritou E, Symeonidis A, Delimpasi S, Pouli A, Vassilakopoulos TP, Michalis E, Giannouli S, Kartasis Z, Christoforidou A, Kokoviadou K, Hatzimichael E, Gika D, Megalakaki C, Papaioannou M, Kyrtsonis MC, Konstantopoulos K, Dimopoulos MA; Greek Myeloma Study Group.

Eur J Haematol. 2017 Nov;99(5):409-414. doi: 10.1111/ejh.12923. Epub 2017 Sep 26.

PMID: 28675766

117.

Dynamic contrast-enhanced magnetic resonance imaging parameters correlate with advanced revised-ISS and angiopoietin-1/angiopoietin-2 ratio in patients with multiple myeloma.

Terpos E, Matsaridis D, Koutoulidis V, Zagouri F, Christoulas D, Fontara S, Panourgias E, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Moulopoulos LA.

Ann Hematol. 2017 Oct;96(10):1707-1714. doi: 10.1007/s00277-017-3078-7. Epub 2017 Aug 1.

PMID: 28766001

118.

Protein expression patterns of cell cycle regulators in operable breast cancer.

Zagouri F, Kotoula V, Kouvatseas G, Sotiropoulou M, Koletsa T, Gavressea T, Valavanis C, Trihia H, Bobos M, Lazaridis G, Koutras A, Pentheroudakis G, Skarlos P, Bafaloukos D, Arnogiannaki N, Chrisafi S, Christodoulou C, Papakostas P, Aravantinos G, Kosmidis P, Karanikiotis C, Zografos G, Papadimitriou C, Fountzilas G.

PLoS One. 2017 Aug 10;12(8):e0180489. doi: 10.1371/journal.pone.0180489. eCollection 2017.

PMID: 28797035 Free PMC article. Clinical Trial.

119.

Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy.

Timotheadou E, Kalogeras KT, Koliou GA, Wirtz RM, Zagouri F, Koutras A, Veltrup E, Christodoulou C, Pentheroudakis G, Tsiftsoglou A, Papakostas P, Aravantinos G, Venizelos V, Pectasides D, Kosmidis P, Karanikiotis C, Markopoulos C, Gogas H, Fountzilas G.

Transl Oncol. 2017 Aug;10(4):589-598. doi: 10.1016/j.tranon.2017.05.006. Epub 2017 Jun 27.

PMID: 28666187 Free PMC article.

120.

Bevacizumab with or after chemotherapy for platinum-resistant recurrent ovarian cancer: exploratory analyses of the AURELIA trial.

Bamias A, Gibbs E, Khoon Lee C, Davies L, Dimopoulos M, Zagouri F, Veillard AS, Kosse J, Santaballa A, Mirza MR, Tabaro G, Vergote I, Bloemendal H, Lykka M, Floquet A, Gebski V, Pujade-Lauraine E.

Ann Oncol. 2017 Aug 1;28(8):1842-1848. doi: 10.1093/annonc/mdx228.

PMID: 28481967 Clinical Trial.

121.

Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation.

Bamias A, Escudier B, Sternberg CN, Zagouri F, Dellis A, Djavan B, Tzannis K, Kontovinis L, Stravodimos K, Papatsoris A, Mitropoulos D, Deliveliotis C, Dimopoulos MA, Constantinides CA.

Oncologist. 2017 Jun;22(6):667-679. doi: 10.1634/theoncologist.2016-0435. Epub 2017 Jun 7.

PMID: 28592625 Free PMC article. Review.

122.

The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy.

Gavressea T, Kalogeras KT, Koliou GA, Zagouri F, Lazaridis G, Gogas H, Tsigaridas K, Koutras A, Petraki K, Markopoulos C, Pazarli E, Aravantinos G, Papadimitriou C, Papakostas P, Koufopoulos N, Karanikiotis C, Chrisafi S, Kalofonos HP, Pectasides D, Fountzilas G, Pavlakis K.

Anticancer Res. 2017 Jun;37(6):2947-2957. doi: 10.21873/anticanres.11648.

PMID: 28551632 Clinical Trial.

123.

Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.

Levva S, Kotoula V, Kostopoulos I, Manousou K, Papadimitriou C, Papadopoulou K, Lakis S, Koukoulias K, Karavasilis V, Pentheroudakis G, Balassi E, Zagouri F, Kaklamanos IG, Pectasides D, Razis E, Aravantinos G, Papakostas P, Bafaloukos D, Rallis G, Gogas H, Fountzilas G.

Cancer Genomics Proteomics. 2017 May-Jun;14(3):181-195. doi: 10.21873/cgp.20030.

PMID: 28446533 Free PMC article.

124.

Bevacizumab increases the incidence of cardiovascular events in patients with metastatic breast or colorectal cancer.

Kapelakis I, Toutouzas K, Drakopoulou M, Michelongona A, Zagouri F, Mpamias A, Pliatsika P, Dimopoulos MA, Stefanadis C, Tousoulis D.

Hellenic J Cardiol. 2017 May-Jun;58(3):215-219. doi: 10.1016/j.hjc.2016.11.022. Epub 2016 Nov 12.

PMID: 28258825

125.

Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group.

Psyrri A, Kalogeras KT, Wirtz RM, Kouvatseas G, Karayannopoulou G, Goussia A, Zagouri F, Veltrup E, Timotheadou E, Gogas H, Koutras A, Lazaridis G, Christodoulou C, Pentheroudakis G, Economopoulou P, Laskarakis A, Arapantoni-Dadioti P, Batistatou A, Sotiropoulou M, Aravantinos G, Papakostas P, Kosmidis P, Pectasides D, Fountzilas G.

J Transl Med. 2017 Feb 13;15(1):30. doi: 10.1186/s12967-017-1134-7.

PMID: 28193231 Free PMC article. Clinical Trial.

126.

Quantitative Diffusion-weighted Imaging of the Bone Marrow: An Adjunct Tool for the Diagnosis of a Diffuse MR Imaging Pattern in Patients with Multiple Myeloma.

Koutoulidis V, Fontara S, Terpos E, Zagouri F, Matsaridis D, Christoulas D, Panourgias E, Kastritis E, Dimopoulos MA, Moulopoulos LA.

Radiology. 2017 Feb;282(2):484-493. doi: 10.1148/radiol.2016160363. Epub 2016 Sep 9.

PMID: 27610934

127.

Breast lymphoma in a patient with B-cell Non Hodgkin Lymphoma: A case report study.

Marinopoulos S, Safioleas P, Skorda L, Vassilopoulou E, Zagouri F, Sotiropoulou M, Drakakis P, Dimitrakakis C.

Int J Surg Case Rep. 2017;40:1-5. doi: 10.1016/j.ijscr.2017.09.003. Epub 2017 Sep 7.

PMID: 28915427 Free PMC article.

128.

The fate of BRCA1-related germline mutations in triple-negative breast tumors.

Kotoula V, Fostira F, Papadopoulou K, Apostolou P, Tsolaki E, Lazaridis G, Manoussou K, Zagouri F, Pectasides D, Vlachos I, Tikas I, Lakis S, Konstantopoulou I, Pentheroudakis G, Gogas H, Papakostas P, Christodoulou C, Bafaloukos D, Razis E, Karavasilis V, Bamias C, Yannoukakos D, Fountzilas G.

Am J Cancer Res. 2017 Jan 1;7(1):98-114. eCollection 2017.

PMID: 28123851 Free PMC article.

129.

Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial.

Sorio R, Roemer-Becuwe C, Hilpert F, Gibbs E, García Y, Kaern J, Huizing M, Witteveen P, Zagouri F, Coeffic D, Lück HJ, González-Martín A, Kristensen G, Levaché CB, Lee CK, Gebski V, Pujade-Lauraine E; AURELIA Investigators.

Gynecol Oncol. 2017 Jan;144(1):65-71. doi: 10.1016/j.ygyno.2016.11.006. Epub 2016 Nov 18.

PMID: 27871723 Clinical Trial.

130.

Disease evolution and heterogeneity in bilateral breast cancer.

Fountzilas E, Kotoula V, Zagouri F, Giannoulatou E, Kouvatseas G, Pentheroudakis G, Koletsa T, Bobos M, Papadopoulou K, Samantas E, Demiri E, Miliaras S, Christodoulou C, Chrisafi S, Razis E, Fostira F, Pectasides D, Zografos G, Fountzilas G.

Am J Cancer Res. 2016 Nov 1;6(11):2611-2630. eCollection 2016.

PMID: 27904775 Free PMC article.

131.

Adding the power of iodinated contrast media to the credibility of mammography in breast cancer diagnosis.

Tsigginou A, Gkali C, Chalazonitis A, Feida E, Vlachos DE, Zagouri F, Rellias I, Dimitrakakis C.

Br J Radiol. 2016 Nov;89(1067):20160397. doi: 10.1259/bjr.20160397. Epub 2016 Aug 9.

PMID: 27452266 Free PMC article.

132.

Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study.

Stavridi F, Kalogeras KT, Pliarchopoulou K, Wirtz RM, Alexopoulou Z, Zagouri F, Veltrup E, Timotheadou E, Gogas H, Koutras A, Lazaridis G, Christodoulou C, Pentheroudakis G, Laskarakis A, Arapantoni-Dadioti P, Batistatou A, Sotiropoulou M, Aravantinos G, Papakostas P, Kosmidis P, Pectasides D, Fountzilas G.

PLoS One. 2016 Oct 3;11(10):e0164013. doi: 10.1371/journal.pone.0164013. eCollection 2016.

PMID: 27695115 Free PMC article.

133.

Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.

Kotoula V, Lakis S, Vlachos IS, Giannoulatou E, Zagouri F, Alexopoulou Z, Gogas H, Pectasides D, Aravantinos G, Efstratiou I, Pentheroudakis G, Papadopoulou K, Chatzopoulos K, Papakostas P, Sotiropoulou M, Nicolaou I, Razis E, Psyrri A, Kosmidis P, Papadimitriou C, Fountzilas G.

PLoS One. 2016 Sep 29;11(9):e0163138. doi: 10.1371/journal.pone.0163138. eCollection 2016.

PMID: 27685159 Free PMC article.

134.

Ocular Surface Disease in Breast Cancer Patients Using Aromatase Inhibitors.

Chatziralli I, Sergentanis T, Zagouri F, Chrysikos D, Ladas I, Zografos GC, Moschos M.

Breast J. 2016 Sep;22(5):561-3. doi: 10.1111/tbj.12633. Epub 2016 Jun 14.

PMID: 27296769

135.

Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial.

Trillsch F, Mahner S, Hilpert F, Davies L, García-Martínez E, Kristensen G, Savarese A, Vuylsteke P, Los M, Zagouri F, Gladieff L, Sehouli J, Khoon Lee C, Gebski V, Pujade-Lauraine E.

Ann Oncol. 2016 Sep;27(9):1733-9. doi: 10.1093/annonc/mdw236. Epub 2016 Jun 10.

PMID: 27287207 Clinical Trial.

136.

Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myeloma.

Zagouri F, Roussou M, Kastritis E, Gavriatopoulou M, Eleutherakis-Papaiakovou E, Kanellias N, Kalapanida D, Christoulas D, Migkou M, Terpos E, Dimopoulos MA.

Leuk Lymphoma. 2016 Aug;57(8):1776-80. doi: 10.3109/10428194.2016.1151513. Epub 2016 Feb 25.

PMID: 26916452

137.

Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.

Kotoula V, Karavasilis V, Zagouri F, Kouvatseas G, Giannoulatou E, Gogas H, Lakis S, Pentheroudakis G, Bobos M, Papadopoulou K, Tsolaki E, Pectasides D, Lazaridis G, Koutras A, Aravantinos G, Christodoulou C, Papakostas P, Markopoulos C, Zografos G, Papandreou C, Fountzilas G.

Breast Cancer Res Treat. 2016 Jul;158(2):307-21. doi: 10.1007/s10549-016-3883-z. Epub 2016 Jul 1.

PMID: 27369359

138.

Emerging antibodies for the treatment of multiple myeloma.

Zagouri F, Terpos E, Kastritis E, Dimopoulos MA.

Expert Opin Emerg Drugs. 2016 Jun;21(2):225-37. doi: 10.1080/14728214.2016.1186644.

PMID: 27195659 Review.

139.

TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.

Fountzilas G, Giannoulatou E, Alexopoulou Z, Zagouri F, Timotheadou E, Papadopoulou K, Lakis S, Bobos M, Poulios C, Sotiropoulou M, Lyberopoulou A, Gogas H, Pentheroudakis G, Pectasides D, Koutras A, Christodoulou C, Papandreou C, Samantas E, Papakostas P, Kosmidis P, Bafaloukos D, Karanikiotis C, Dimopoulos MA, Kotoula V.

Oncotarget. 2016 May 31;7(22):32731-53. doi: 10.18632/oncotarget.9022.

PMID: 27129168 Free PMC article.

140.

Cancer in pregnancy: disentangling treatment modalities.

Zagouri F, Dimitrakakis C, Marinopoulos S, Tsigginou A, Dimopoulos MA.

ESMO Open. 2016 May 4;1(3):e000016. doi: 10.1136/esmoopen-2015-000016. eCollection 2016.

PMID: 27843602 Free PMC article. Review.

141.

Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer.

Lakis S, Dimoudis S, Kotoula V, Alexopoulou Z, Kostopoulos I, Koletsa T, Bobos M, Timotheadou E, Papaspirou I, Efstratiou I, Aravantinos G, Karavasilis V, Zagouri F, Gogas H, Razis E, Pentheroudakis G, Christodoulou C, Pectasides D, Fountzilas G.

Anticancer Res. 2016 May;36(5):2365-78.

PMID: 27127145

142.

Electroretinographic and optical coherence tomography findings in breast cancer patients using aromatase inhibitors.

Moschos MM, Chatziralli IP, Sergentanis T, Zagouri F, Chrysikos D, Ladas I, Zografos G.

Cutan Ocul Toxicol. 2016 Mar;35(1):13-20. doi: 10.3109/15569527.2014.1003267. Epub 2015 Jan 19.

PMID: 25597370 Clinical Trial.

143.

Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials.

Kotoula V, Chatzopoulos K, Lakis S, Alexopoulou Z, Timotheadou E, Zagouri F, Pentheroudakis G, Gogas H, Galani E, Efstratiou I, Zaramboukas T, Koutras A, Aravantinos G, Samantas E, Psyrri A, Kourea H, Bobos M, Papakostas P, Kosmidis P, Pectasides D, Fountzilas G.

Oncotarget. 2016 Jan 26;7(4):5074-87. doi: 10.18632/oncotarget.6231.

PMID: 26506242 Free PMC article.

144.

Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study.

Papaxoinis G, Kotoula V, Alexopoulou Z, Kalogeras KT, Zagouri F, Timotheadou E, Gogas H, Pentheroudakis G, Christodoulou C, Koutras A, Bafaloukos D, Aravantinos G, Papakostas P, Charalambous E, Papadopoulou K, Varthalitis I, Efstratiou I, Zaramboukas T, Patsea H, Scopa CD, Skondra M, Kosmidis P, Pectasides D, Fountzilas G.

PLoS One. 2015 Oct 9;10(10):e0140293. doi: 10.1371/journal.pone.0140293. eCollection 2015.

PMID: 26452060 Free PMC article. Clinical Trial.

145.

Risk Factors for Multiple Myeloma: A Systematic Review of Meta-Analyses.

Sergentanis TN, Zagouri F, Tsilimidos G, Tsagianni A, Tseliou M, Dimopoulos MA, Psaltopoulou T.

Clin Lymphoma Myeloma Leuk. 2015 Oct;15(10):563-77.e1-3. doi: 10.1016/j.clml.2015.06.003. Epub 2015 Jun 19.

PMID: 26294217 Review.

146.

Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study.

Kourea HP, Kotoula V, Koutras A, Alexopoulou Z, Papaspirou I, Skarlos DV, Efstratiou I, Bobos M, Zagouri F, Papakostas P, Pectasides D, Chrisafi S, Varthalitis I, Aravantinos G, Kosmidis P, Bafaloukos D, Scopa CD, Fountzilas G.

Histol Histopathol. 2015 Sep;30(9):1129-41. doi: 10.14670/HH-11-612. Epub 2015 Mar 25.

PMID: 25807307 Clinical Trial.

147.

Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review.

Zagouri F, Sergentanis TN, Chrysikos D, Dimopoulos MA, Bamias A.

Onco Targets Ther. 2015 Aug 20;8:2187-98. doi: 10.2147/OTT.S77342. eCollection 2015.

PMID: 26316786 Free PMC article.

148.

Cumulative BRCA mutation analysis in the Greek population confirms that homogenous ethnic background facilitates genetic testing.

Tsigginou A, Vlachopoulos F, Arzimanoglou I, Zagouri F, Dimitrakakis C.

Hered Cancer Clin Pract. 2015 Aug 19;13(1):17. doi: 10.1186/s13053-015-0037-y. eCollection 2015.

PMID: 26300996 Free PMC article.

149.

Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal.

Zagouri F, Liakou P, Bartsch R, Peccatori FA, Tsigginou A, Dimitrakakis C, Zografos GC, Dimopoulos MA, Azim HA Jr.

Breast. 2015 Aug;24(4):513-23. doi: 10.1016/j.breast.2015.02.031. Epub 2015 Mar 25.

PMID: 25818651 Review.

150.

Expression of ARs in triple negative breast cancer tumors: a potential prognostic factor?

Giannos A, Filipits M, Zagouri F, Brandstetter A, Tsigginou A, Sotiropoulou M, Papaspyrou I, Sergentanis TN, Psaltopoulou T, Rodolakis A, Antsaklis A, Dimopoulos MA, Dimitrakakis C.

Onco Targets Ther. 2015 Jul 23;8:1843-7. doi: 10.2147/OTT.S78254. eCollection 2015.

PMID: 26229492 Free PMC article.

151.

Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.

Linardou H, Kalogeras KT, Kronenwett R, Alexopoulou Z, Wirtz RM, Zagouri F, Scopa CD, Gogas H, Petraki K, Christodoulou C, Pavlakis K, Koutras AK, Samantas E, Patsea H, Pectasides D, Bafaloukos D, Fountzilas G.

Anticancer Res. 2015 Jul;35(7):4023-36.

PMID: 26124351 Clinical Trial.

152.

Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study.

Koutras A, Kalogeras KT, Wirtz RM, Alexopoulou Z, Bobos M, Zagouri F, Veltrup E, Timotheadou E, Gogas H, Pentheroudakis G, Pisanidis N, Magkou C, Christodoulou C, Bafaloukos D, Papakostas P, Aravantinos G, Pectasides D, Kalofonos HP, Fountzilas G.

J Transl Med. 2015 May 29;13:171. doi: 10.1186/s12967-015-0530-0.

PMID: 26021752 Free PMC article.

153.

Aromatase inhibitors in male breast cancer: a pooled analysis.

Zagouri F, Sergentanis TN, Azim HA Jr, Chrysikos D, Dimopoulos MA, Psaltopoulou T.

Breast Cancer Res Treat. 2015 May;151(1):141-7. doi: 10.1007/s10549-015-3356-9. Epub 2015 Apr 8.

PMID: 25850534

154.

Lazaroid U-74389G Administration in Pancreatic Ischemia-Reperfusion Injury: A Swine Model Encompassing Ischemic Preconditioning.

Chrysikos DT, Sergentanis TN, Zagouri F, Psaltopoulou T, Theodoropoulos G, Flessas I, Agrogiannis G, Alexakis N, Lymperi M, Katsarou AI, Patsouris ES, Zografos CG, Papalois AE.

JOP. 2015 Mar 20;16(2):176-84. doi: 10.6092/1590-8577/2952.

PMID: 25791552

155.

Immunohistochemical expression of sex steroid hormone receptors, cell cycle regulators and angiogenesis factors in intraductal papillary mucinous neoplasms: an explorative study.

Georgiadou D, Sergentanis TN, Sakellariou S, Filippakis GM, Zagouri F, Psaltopoulou T, Lazaris AC, Patsouris E, Gounaris A, Zografos GC.

Anticancer Res. 2015 Feb;35(2):1049-56.

PMID: 25667493

156.

An update on the use of lenalidomide for the treatment of multiple myeloma.

Zagouri F, Terpos E, Kastritis E, Dimopoulos MA.

Expert Opin Pharmacother. 2015;16(12):1865-77. doi: 10.1517/14656566.2015.1067681. Epub 2015 Jul 13.

PMID: 26165832 Review.

157.

Pseudomamma of the inguinal region in a female patient: A case report.

Marinopoulos S, Arampatzis I, Zagouri F, Dimitrakakis C.

Int J Surg Case Rep. 2015;12:71-4. doi: 10.1016/j.ijscr.2015.05.021. Epub 2015 May 19.

PMID: 26011805 Free PMC article.

158.

Fulvestrant and male breast cancer: a pooled analysis.

Zagouri F, Sergentanis TN, Chrysikos D, Dimopoulos MA, Psaltopoulou T.

Breast Cancer Res Treat. 2015 Jan;149(1):269-75. doi: 10.1007/s10549-014-3240-z. Epub 2014 Dec 18.

PMID: 25519043

159.

Current clinical practice guidelines on chemotherapy and radiotherapy for the treatment of non-metastatic muscle-invasive urothelial cancer: a systematic review and critical evaluation by the Hellenic Genito-Urinary Cancer Group (HGUCG).

Zagouri F, Peroukidis S, Tzannis K, Kouloulias V, Bamias A; Hellenic Genito-Urinary Cancer Group (HCUCG).

Crit Rev Oncol Hematol. 2015 Jan;93(1):36-49. doi: 10.1016/j.critrevonc.2014.08.005. Epub 2014 Aug 27.

PMID: 25205597 Review.

160.

Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis.

Georgiadou D, Sergentanis TN, Sakellariou S, Filippakis GM, Zagouri F, Vlachodimitropoulos D, Psaltopoulou T, Lazaris AC, Patsouris E, Zografos GC.

APMIS. 2014 Dec;122(12):1230-9. doi: 10.1111/apm.12289. Epub 2014 Jul 22.

PMID: 25053516

161.

Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer.

Bergen E, Berghoff AS, Rudas M, Dubsky P, De Vries C, Sattlberger C, Mader RM, Zagouri F, Sparber C, Fitzal F, Gnant M, Rottenfusser A, Zielinski CC, Preusser M, Steger GG, Bartsch R.

Breast Care (Basel). 2014 Oct;9(5):344-8. doi: 10.1159/000368330.

PMID: 25759615 Free PMC article.

162.

Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer.

Pentheroudakis G, Kotoula V, Kouvatseas G, Charalambous E, Dionysopoulos D, Zagouri F, Koutras A, Papazisis K, Pectasides D, Samantas E, Dimopoulos MA, Papandreou CN, Fountzilas G.

Clin Breast Cancer. 2014 Oct;14(5):330-8. doi: 10.1016/j.clbc.2014.02.009. Epub 2014 Mar 1.

PMID: 24703319 Clinical Trial.

163.

Preserved levels of uninvolved immunoglobulins are independently associated with favorable outcome in patients with symptomatic multiple myeloma.

Kastritis E, Zagouri F, Symeonidis A, Roussou M, Sioni A, Pouli A, Delimpasi S, Katodritou E, Michalis E, Michael M, Hatzimichael E, Vassou A, Repousis P, Christophoridou A, Kartasis Z, Stefanoudaki E, Megalakaki C, Giannouli S, Kyrtsonis MC, Konstantopoulos K, Spyroupoulou-Vlachou M, Terpos E, Dimopoulos MA; Greek Myeloma Study Group.

Leukemia. 2014 Oct;28(10):2075-9. doi: 10.1038/leu.2014.110. Epub 2014 Mar 18.

PMID: 24637336

164.

VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis.

Georgiadou D, Sergentanis TN, Sakellariou S, Filippakis GM, Zagouri F, Vlachodimitropoulos D, Psaltopoulou T, Lazaris AC, Patsouris E, Zografos GC.

Eur J Surg Oncol. 2014 Oct;40(10):1331-7. doi: 10.1016/j.ejso.2014.01.004. Epub 2014 Jan 18.

PMID: 24480377

165.

Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis.

Zagouri F, Kastritis E, Gavriatopoulou M, Sergentanis TN, Psaltopoulou T, Terpos E, Dimopoulos MA.

Leuk Lymphoma. 2014 Sep;55(9):2018-23. doi: 10.3109/10428194.2013.869329. Epub 2014 Feb 17.

PMID: 24295131 Review.

166.

Gynecologic oncology patients in the surgical high dependency unit: an analysis of indications.

Thomakos N, Zacharakis D, Rodolakis A, Zagouri F, Papadimitriou CA, Bamias A, Dimopoulos MA, Haidopoulos D, Vlahos G, Antsaklis A.

Arch Gynecol Obstet. 2014 Aug;290(2):335-9. doi: 10.1007/s00404-014-3180-1. Epub 2014 Mar 18.

PMID: 24639289

167.

Female breast cancer in Europe: statistics, diagnosis and treatment modalities.

Zagouri F, Sergentanis TN, Tsigginou A, Dimitrakakis C, Zografos GC, Dimopoulos MA, Psaltopoulou T.

J Thorac Dis. 2014 Jun;6(6):589-90. doi: 10.3978/j.issn.2072-1439.2014.06.18.

PMID: 24976977 Free PMC article. No abstract available.

168.

The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.

Lakis S, Kotoula V, Eleftheraki AG, Batistatou A, Bobos M, Koletsa T, Timotheadou E, Chrisafi S, Pentheroudakis G, Koutras A, Zagouri F, Linardou H, Fountzilas G.

Breast. 2014 Jun;23(3):234-43. doi: 10.1016/j.breast.2014.02.013. Epub 2014 Apr 3.

PMID: 24703723 Clinical Trial.

169.

Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel.

Koutras AK, Kotoula V, Papadimitriou C, Dionysopoulos D, Zagouri F, Kalofonos HP, Kourea HP, Skarlos DV, Samantas E, Papadopoulou K, Kosmidis P, Pectasides D, Fountzilas G.

Pharmacogenomics J. 2014 Jun;14(3):248-55. doi: 10.1038/tpj.2013.36. Epub 2013 Sep 24.

PMID: 24061601

170.

Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents.

Zagouri F, Kastritis E, Symeonidis AS, Giannakoulas N, Katodritou E, Delimpasi S, Repousis P, Terpos E, Dimopoulos MA; Greek Myeloma Study Group.

Eur J Haematol. 2014 Apr;92(4):308-12. doi: 10.1111/ejh.12255. Epub 2014 Jan 26.

PMID: 24460646

171.

The effect of U-74389G on pancreas ischemia-reperfusion injury in a swine model.

Chrysikos DT, Sergentanis TN, Zagouri F, Psaltopoulou T, Flessas I, Agrogiannis G, Alexakis N, Bramis I, Patsouri EE, Patsouris ES, Korontzi M, Katsarou A, Zografos GC, Papalois AE.

J Surg Res. 2014 Apr;187(2):450-7. doi: 10.1016/j.jss.2013.11.1082. Epub 2013 Nov 16.

PMID: 24332939

172.

Low protein expression of MET in ER-positive and HER2-positive breast cancer.

Zagouri F, Brandstetter A, Moussiolis D, Chrysikos D, Dimitrakakis C, Tsigginou A, Marinopoulos S, Zografos GC, Sergentanis TN, Dimopoulos MA, Filipits M.

Anticancer Res. 2014 Mar;34(3):1227-31.

PMID: 24596364

173.

Hsp90 inhibitors in breast cancer: a systematic review.

Zagouri F, Sergentanis TN, Chrysikos D, Papadimitriou CA, Dimopoulos MA, Psaltopoulou T.

Breast. 2013 Oct;22(5):569-78. doi: 10.1016/j.breast.2013.06.003. Epub 2013 Jul 17.

PMID: 23870456 Review.

174.

Pertuzumab in breast cancer: a systematic review.

Zagouri F, Sergentanis TN, Chrysikos D, Zografos CG, Filipits M, Bartsch R, Dimopoulos MA, Psaltopoulou T.

Clin Breast Cancer. 2013 Oct;13(5):315-24. doi: 10.1016/j.clbc.2013.05.002. Epub 2013 Jun 27.

PMID: 23810292 Review.

175.

MMP-2 -1306C>T polymorphism in breast cancer: a case-control study in a South European population.

Zagouri F, Sergentanis TN, Gazouli M, Dimitrakakis C, Tsigginou A, Papaspyrou I, Chrysikos D, Lymperi M, Zografos GC, Antsaklis A, Dimopoulos MA, Papadimitriou CA.

Mol Biol Rep. 2013 Aug;40(8):5035-40. doi: 10.1007/s11033-013-2604-5. Epub 2013 May 10.

PMID: 23661021

176.

Molecularly targeted therapies in metastatic pancreatic cancer: a systematic review.

Zagouri F, Sergentanis TN, Chrysikos D, Zografos CG, Papadimitriou CA, Dimopoulos MA, Filipits M, Bartsch R.

Pancreas. 2013 Jul;42(5):760-73. doi: 10.1097/MPA.0b013e31827aedef.

PMID: 23774698 Review.

177.

Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series.

Zagouri F, Sergentanis TN, Koutoulidis V, Sparber C, Steger GG, Dubsky P, Zografos GC, Psaltopoulou T, Gnant M, Dimopoulos MA, Bartsch R.

Br J Cancer. 2013 Jun 11;108(11):2259-63. doi: 10.1038/bjc.2013.255. Epub 2013 May 30.

PMID: 23722469 Free PMC article.

178.

Does pregnancy-associated breast cancer imply a worse prognosis? A matched case-case study.

Dimitrakakis C, Zagouri F, Tsigginou A, Marinopoulos S, Sergentanis TN, Keramopoulos A, Zografos GC, Ampela K, Mpaltas D, Papadimitriou C, Dimopoulos MA, Antsaklis A.

Breast Care (Basel). 2013 Jun;8(3):203-7. doi: 10.1159/000352093.

PMID: 24415971 Free PMC article.

179.

Challenges in managing breast cancer during pregnancy.

Zagouri F, Psaltopoulou T, Dimitrakakis C, Bartsch R, Dimopoulos MA.

J Thorac Dis. 2013 Jun;5 Suppl 1(Suppl 1):S62-7. doi: 10.3978/j.issn.2072-1439.2013.05.21.

PMID: 23819029 Free PMC article.

180.

Breast cancer in women aged 25 years and younger.

Dimitrakakis C, Tsigginou A, Zagouri F, Marinopoulos S, Sergentanis TN, Keramopoulos A, Liakou P, Zografos GC, Papadimitriou CA, Dimopoulos MA, Antsaklis A.

Obstet Gynecol. 2013 Jun;121(6):1235-1240. doi: 10.1097/AOG.0b013e318291ef9a.

PMID: 23812457

181.

Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis.

Zagouri F, Sergentanis TN, Bartsch R, Berghoff AS, Chrysikos D, de Azambuja E, Dimopoulos MA, Preusser M.

Breast Cancer Res Treat. 2013 May;139(1):13-22. doi: 10.1007/s10549-013-2525-y. Epub 2013 Apr 16.

PMID: 23588955 Review.

182.

Estimation of maspin’s subcellular localization in invasive ductal breast cancer via light microscopy and computerized image analysis: a comparative study.

Panou M, Kavantzas N, Sergentanis T, Sakellariou S, Agrogiannis G, Chatzipantelis P, Anastasopoulou E, Soranoglou V, Zagouri F, Korkolopoulou P, Patsouris E, Bramis I, Zografos GC.

J BUON. 2013 Apr-Jun;18(2):342-51.

PMID: 23818344

183.

High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer.

Zagouri F, Bago-Horvath Z, Rössler F, Brandstetter A, Bartsch R, Papadimitriou CA, Dimitrakakis C, Tsigginou A, Papaspyrou I, Giannos A, Dimopoulos MA, Filipits M.

Br J Cancer. 2013 Mar 19;108(5):1100-5. doi: 10.1038/bjc.2013.31. Epub 2013 Feb 19.

PMID: 23422757 Free PMC article.

184.

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement.

Azim HA Jr, Michiels S, Zagouri F, Delaloge S, Filipits M, Namer M, Neven P, Symmans WF, Thompson A, André F, Loi S, Swanton C.

Ann Oncol. 2013 Mar;24(3):647-54. doi: 10.1093/annonc/mds645. Epub 2013 Jan 20.

PMID: 23337633 Free PMC article.

185.

Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis.

Zagouri F, Sergentanis TN, Chrysikos D, Bartsch R.

Obstet Gynecol. 2013 Feb;121(2 Pt 1):337-343. doi: 10.1097/AOG.0b013e31827c5822.

PMID: 23344284 Review.

186.

Prophylactic mastectomy: an appraisal.

Zagouri F, Chrysikos DT, Sergentanis TN, Giannakopoulou G, Zografos CG, Papadimitriou CA, Zografos GC.

Am Surg. 2013 Feb;79(2):205-12.

PMID: 23336662 Review.

187.

Taxanes for breast cancer during pregnancy: a systematic review.

Zagouri F, Sergentanis TN, Chrysikos D, Dimitrakakis C, Tsigginou A, Zografos CG, Dimopoulos MA, Papadimitriou CA.

Clin Breast Cancer. 2013 Feb;13(1):16-23. doi: 10.1016/j.clbc.2012.09.014. Epub 2012 Nov 2.

PMID: 23122538 Review.

188.

Screening in the era of economic crisis: misperceptions and misuse from a longitudinal study on Greek women undergoing benign vacuum-assisted breast biopsy.

Domeyer PJ, Sergentanis TN, Katsari V, Souliotis K, Mariolis A, Zagouri F, Zografos GC.

Asian Pac J Cancer Prev. 2013;14(9):5023-9. doi: 10.7314/apjcp.2013.14.9.5023.

PMID: 24175770

189.

Beta-thalassemia major: does it confer particularities to the breast?

Bletsa G, Zagouri F, Gounaris A, Chrysikos D, Theodoropoulos G, Lymperi M, Koulocheri D, Menenakos E, Zografos GC, Sergentanis TN.

Breast J. 2013 Jan-Feb;19(1):124-5. doi: 10.1111/tbj.12066.

PMID: 23301764 No abstract available.

190.

Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents.

Bamias A, Bamia C, Zagouri F, Kostouros E, Kakoyianni K, Rodolakis A, Vlahos G, Haidopoulos D, Thomakos N, Antsaklis A, Dimopoulos MA.

Oncology. 2013;84(3):158-65. doi: 10.1159/000341366. Epub 2012 Dec 28.

PMID: 23296063

191.

Fulvestrant and male breast cancer: a case series.

Zagouri F, Sergentanis TN, Chrysikos D, Zografos E, Rudas M, Steger G, Zografos G, Bartsch R.

Ann Oncol. 2013 Jan;24(1):265-6. doi: 10.1093/annonc/mds597.

PMID: 23251011 No abstract available.

192.

Trastuzumab administration during pregnancy: a systematic review and meta-analysis.

Zagouri F, Sergentanis TN, Chrysikos D, Papadimitriou CA, Dimopoulos MA, Bartsch R.

Breast Cancer Res Treat. 2013 Jan;137(2):349-57. doi: 10.1007/s10549-012-2368-y. Epub 2012 Dec 15.

PMID: 23242615 Review.

193.

Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?

Thomakos N, Rodolakis A, Zagouri F, Zacharakis D, Sotiropoulou M, Akrivos N, Haidopoulos D, Papadimitriou CA, Dimopoulos MA, Antsaklis A.

Arch Gynecol Obstet. 2013 Jan;287(1):97-102. doi: 10.1007/s00404-012-2529-6. Epub 2012 Sep 1.

PMID: 22941327

194.

HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study.

Zagouri F, Sergentanis TN, Gazouli M, Tsigginou A, Dimitrakakis C, Papaspyrou I, Eleutherakis-Papaiakovou E, Chrysikos D, Theodoropoulos G, Zografos GC, Antsaklis A, Dimopoulos AM, Papadimitriou CA.

Mol Biol Rep. 2012 Dec;39(12):10873-9. doi: 10.1007/s11033-012-1984-2. Epub 2012 Oct 12.

PMID: 23065205

195.

HTERT MNS16A polymorphism in breast cancer: a case-control study.

Zagouri F, Sergentanis TN, Gazouli M, Tsigginou A, Dimitrakakis C, Eleutherakis-Papaiakovou E, Papaspyrou I, Chrysikos D, Theodoropoulos G, Zografos GC, Antsaklis A, Dimopoulos AM, Papadimitriou CA.

Mol Biol Rep. 2012 Dec;39(12):10859-63. doi: 10.1007/s11033-012-1982-4. Epub 2012 Oct 12.

PMID: 23065203

196.

mTOR inhibitors in breast cancer: a systematic review.

Zagouri F, Sergentanis TN, Chrysikos D, Filipits M, Bartsch R.

Gynecol Oncol. 2012 Dec;127(3):662-72. doi: 10.1016/j.ygyno.2012.08.040. Epub 2012 Sep 9.

PMID: 22967800 Review.

197.

The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.

Linardou H, Kalogeras KT, Kronenwett R, Kouvatseas G, Wirtz RM, Zagouri F, Gogas H, Christodoulou C, Koutras AK, Samantas E, Pectasides D, Bafaloukos D, Fountzilas G.

Breast Cancer Res. 2012 Nov 12;14(6):R145. doi: 10.1186/bcr3354.

PMID: 23146280 Free PMC article. Clinical Trial.

198.

Dual carcinoma of the breast with neuroendocrine differentiation.

Flessas I, Tsamis D, Michalopoulos NV, Chrysikos D, Liakou P, Linardoutsos D, Zagouri F, Zografos G.

Am Surg. 2012 Nov;78(11):E457-8.

PMID: 23089417 No abstract available.

199.

Neurofibromatosis 1 and breast cancer: be alert.

Zagouri F, Sergentanis TN, Domeyer P, Zografos GC.

Am Surg. 2012 Nov;78(11):E446-7.

PMID: 23089412 No abstract available.

200.

A woman with breast cancer and severe impaired lactose tolerance: an intriguing therapeutic dilemma.

Zagouri F, Dimitrakakis C, Dimopoulos MA, Tsigginou A, Antsaklis A, Papadimitriou CA.

Breast J. 2012 Nov-Dec;18(6):628-9. doi: 10.1111/tbj.12019. Epub 2012 Sep 26.

PMID: 23009609 No abstract available.

201.

Macular oedema due to letrozole: a first case report.

Moschos MM, Chatziralli IP, Zagouri F, Zografos GC.

Clin Exp Optom. 2012 Nov;95(6):646-50. doi: 10.1111/j.1444-0938.2012.00771.x. Epub 2012 Aug 13.

PMID: 22882318

202.

Heat shock protein 90 (hsp90) expression and breast cancer.

Zagouri F, Bournakis E, Koutsoukos K, Papadimitriou CA.

Pharmaceuticals (Basel). 2012 Sep 12;5(9):1008-20. doi: 10.3390/ph5091008.

PMID: 24280702 Free PMC article.

203.

Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development.

Theodoropoulos GE, Saridakis V, Karantanos T, Michalopoulos NV, Zagouri F, Kontogianni P, Lymperi M, Gazouli M, Zografos GC.

Breast. 2012 Aug;21(4):534-8. doi: 10.1016/j.breast.2012.04.001. Epub 2012 May 2.

PMID: 22560646

204.

Molecularly targeted therapies in cervical cancer. A systematic review.

Zagouri F, Sergentanis TN, Chrysikos D, Filipits M, Bartsch R.

Gynecol Oncol. 2012 Aug;126(2):291-303. doi: 10.1016/j.ygyno.2012.04.007. Epub 2012 Apr 11.

PMID: 22504292 Review.

205.

Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor.

Bamias A, Sotiropoulou M, Zagouri F, Trachana P, Sakellariou K, Kostouros E, Kakoyianni K, Rodolakis A, Vlahos G, Haidopoulos D, Thomakos N, Antsaklis A, Dimopoulos MA.

Eur J Cancer. 2012 Jul;48(10):1476-83. doi: 10.1016/j.ejca.2011.09.023. Epub 2011 Oct 31.

PMID: 22047635

206.

Mucinous tubular and spindle cell carcinoma of the kidney: a case report.

Chrysikos D, Zagouri F, Sergentanis TN, Goutas N, Vlachodimitropoulos D, Flessas I, Theodoropoulos G, Lymperi M, Birbas K, Zografos GC, Mariolis-Sapsakos T.

Case Rep Oncol. 2012 May;5(2):347-53. doi: 10.1159/000339802. Epub 2012 Jul 3.

PMID: 22807903 Free PMC article.

207.

Laparoscopic repair of giant paraesophageal hernia with synthetic mesh: 45 consecutive cases.

Stavropoulos G, Flessas II, Mariolis-Sapsakos T, Zagouri F, Theodoropoulos G, Toutouzas K, Michalopoulos NV, Triantafyllopoulou I, Tsamis D, Spyropoulos BG, Zografos GC.

Am Surg. 2012 Apr;78(4):432-5.

PMID: 22472400

208.

Soluble human leukocyte antigen-G expression in patients with ductal and lobular breast malignancy.

Provatopoulou X, Kalogera E, Sagkriotis A, Zagouri F, Nonni A, Zografos GC, Gounaris A.

Anticancer Res. 2012 Mar;32(3):1021-6.

PMID: 22399626

209.

Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer.

Stefanadis C, Synetos A, Tousoulis D, Tsiamis E, Michelongona A, Zagouri F, Bamias A, Dimopoulos MA, Kyvelou S, Kapelakis I, Toutouzas K.

Int J Cardiol. 2012 Feb 9;154(3):341-4. doi: 10.1016/j.ijcard.2011.10.115. Epub 2011 Nov 9.

PMID: 22078988 No abstract available.

210.

Taxanes for ovarian cancer during pregnancy: a systematic review.

Zagouri F, Sergentanis TN, Chrysikos D, Filipits M, Bartsch R.

Oncology. 2012;83(4):234-8. doi: 10.1159/000341351. Epub 2012 Aug 16.

PMID: 22907101 Review.

211.

Merkel cell carcinoma in pelvic lymph nodes after surgical staging for endometrial cancer: A case report and review of the literature.

Thomakos N, Zacharakis D, Akrivos N, Zagouri F, Simou M, Bamias A, Dimopoulos MA, Rodolakis A, Antsaklis A.

Int J Surg Case Rep. 2012;3(7):340-2. doi: 10.1016/j.ijscr.2012.03.027. Epub 2012 Apr 5.

PMID: 22580079 Free PMC article.

212.

Quiz case: a 19-year-old woman with hypercalcemia and abdominal pain.

Zagouri F, Thomakos N, Rodolakis A, Bamias A, Chalazonitis A, Sotiropoulou M, Antsaklis A, Dimopoulos MA, Papadimitriou CA.

Onkologie. 2012;35(3):126-7. doi: 10.1159/000336973. Epub 2012 Feb 21.

PMID: 22414978 No abstract available.

213.

Molecularly targeted therapies in unresectable-metastatic gastric cancer: a systematic review.

Zagouri F, Papadimitriou CA, Dimopoulos MA, Pectasides D.

Cancer Treat Rev. 2011 Dec;37(8):599-610. doi: 10.1016/j.ctrv.2011.03.007. Epub 2011 Jun 14.

PMID: 21676549 Review.

214.

Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes.

Simou M, Thomakos N, Zagouri F, Vlysmas A, Akrivos N, Zacharakis D, Papadimitriou CA, Dimopoulos MA, Rodolakis A, Antsaklis A.

World J Surg Oncol. 2011 Nov 3;9:142. doi: 10.1186/1477-7819-9-142.

PMID: 22051161 Free PMC article. Review.

215.

Lenalidomide-associated pneumonitis in patients with plasma cell dyscrasias.

Zagouri F, Roussou M, Kastritis E, Koureas A, Tsokou E, Migkou M, Gavriatopoulou M, Nikitas N, Gkotzamanidou M, Terpos E, Dimopoulos MA.

Am J Hematol. 2011 Oct;86(10):882-4. doi: 10.1002/ajh.22135. Epub 2011 Aug 4.

PMID: 21818766 No abstract available.

216.

Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience.

Bamias A, Karadimou A, Soupos N, Sotiropoulou M, Zagouri F, Haidopoulos D, Thomakos N, Rodolakis A, Antsaklis A, Dimopoulos MA.

Gynecol Oncol. 2011 Oct;123(1):37-42. doi: 10.1016/j.ygyno.2011.06.033. Epub 2011 Jul 18.

PMID: 21764430

217.

Vacuum-assisted breast biopsy: more cores, more hematomas?

Zagouri F, Gounaris A, Liakou P, Chrysikos D, Flessas I, Bletsa G, Giannakopoulou G, Michalopoulos NV, Safioleas P, Zografos GC, Sergentanis TN.

In Vivo. 2011 Jul-Aug;25(4):703-5.

PMID: 21709018 Clinical Trial.

218.

Serum levels of HSP90 in the continuum of breast ductal and lobular lesions.

Zagouri F, Sergentanis TN, Provatopoulou X, Kalogera E, Chrysikos D, Lymperi M, Papadimitriou CA, Zografos E, Bletsa G, Kalles VS, Zografos GC, Gounaris A.

In Vivo. 2011 Jul-Aug;25(4):669-72.

PMID: 21709012

219.

Cutaneous metastasis of signet-ring gastric adenocarcinoma to the breast with unusual clinicopathological features.

Avgerinou G, Flessas I, Hatziolou E, Zografos G, Nitsios I, Zagouri F, Katsambas A, Kanitakis J.

Anticancer Res. 2011 Jun;31(6):2373-8.

PMID: 21737667

220.

Mucocelelike lesions and vacuum-assisted breast biopsy: advantages and particularities.

Zografos GC, Zagouri F, Sergentanis TN.

AJR Am J Roentgenol. 2011 May;196(5):W665. doi: 10.2214/AJR.08.1161.

PMID: 21512061 No abstract available.

221.

Carcinomatous meningitis from transitional cell carcinoma of the urinary bladder.

Kastritis E, Zagouri F, Dimopoulos MA, Papadimitriou CA.

J BUON. 2011 Apr-Jun;16(2):373-4.

PMID: 21766515 No abstract available.

222.

Effects of lazaroids on intestinal ischemia and reperfusion injury in experimental models.

Flessas II, Papalois AE, Toutouzas K, Zagouri F, Zografos GC.

J Surg Res. 2011 Apr;166(2):265-74. doi: 10.1016/j.jss.2010.08.031. Epub 2010 Sep 15.

PMID: 21092988 Review.

223.

Serum MMPs and TIMPs: may be predictors of breast carcinogenesis?

Zagouri F, Sergentanis TN, Kalogera E, Provatopoulou X, Chrysikos D, Zografos E, Bletsa G, Flessas I, Papadimitriou CA, Zografos GC, Gounaris A.

Clin Chim Acta. 2011 Mar 18;412(7-8):537-40. doi: 10.1016/j.cca.2010.11.037. Epub 2010 Dec 3.

PMID: 21130755

224.

Cholangiocarcinoma: principles and current trends.

Zografos GN, Farfaras A, Zagouri F, Chrysikos D, Karaliotas K.

Hepatobiliary Pancreat Dis Int. 2011 Feb;10(1):10-20. doi: 10.1016/s1499-3872(11)60001-5.

PMID: 21269929 Review.

225.

A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: time-dependent effect of 4 versus 6 cycles on outcome.

Bamias A, Bamia C, Karadimou A, Soupos N, Zagouri F, Rodolakis A, Haidopoulos D, Vlahos G, Thomakos N, Antsaklis A, Dimopoulos MA.

Oncology. 2011;81(5-6):365-71. doi: 10.1159/000334230. Epub 2012 Jan 13.

PMID: 22248920

226.

Tumor dissemination after laparoscopic surgery for an unsuspected endometrial stromal tumor.

Pavlakis K, Messini I, Papadimitriou CA, Zagouri F, Yiannou P, Mavrelos D, Panoskaltis T.

Eur J Gynaecol Oncol. 2011;32(3):362-3.

PMID: 21797138

227.

Systemic chemotherapy with pemetrexed and cisplatin for malignant peritoneal mesothelioma: a single institution experience.

Lainakis G, Zagouri F, Kastritis E, Sergentanis TN, Bozas G, Dimopoulos MA, Papadimitriou CA.

Tumori. 2011 Jan-Feb;97(1):25-9. doi: 10.1177/030089161109700105.

PMID: 21528659 Clinical Trial.

228.

Breast lesions in patients with Mazabraud or McCune-Albright syndrome.

Michalopoulos NV, Tsamis D, Linardoutsos D, Flessas I, Zagouri F, Liakou P, Filippakis GM, Zografos GC.

Am Surg. 2011 Jan;77(1):E7-8.

PMID: 21396290 Review. No abstract available.

229.

Sarcomas of the fallopian tube: disentangling a rare entity.

Zagouri F, Dimopoulos MA, Thomakos N, Chrysikos D, Papadimitriou CA.

Onkologie. 2011;34(3):132-8. doi: 10.1159/000324792. Epub 2011 Feb 21.

PMID: 21358220 Review.

230.

Gestational trophoblastic neoplasia with retroperitoneal metastases: a fatal complication.

Thomakos N, Rodolakis A, Belitsos P, Zagouri F, Chatzinikolaou I, Dimopoulos AM, Papadimitriou CA, Antsaklis A.

World J Surg Oncol. 2010 Dec 30;8:114. doi: 10.1186/1477-7819-8-114.

PMID: 21192785 Free PMC article.

231.

Downgrading BIRADS 3 to BIRADS 2 category using a computer-aided microcalcification analysis and risk assessment system for early breast cancer.

Giannakopoulou G, Spyrou GM, Antaraki A, Andreadis I, Koulocheri D, Zagouri F, Nonni A, Filippakis GM, Nikita KS, Ligomenides PA, Zografos GC.

Comput Biol Med. 2010 Nov-Dec;40(11-12):853-9. doi: 10.1016/j.compbiomed.2010.09.005. Epub 2010 Oct 14.

PMID: 20950798

232.

Is antibiotic use a risk factor for breast cancer? A meta-analysis.

Sergentanis TN, Zagouri F, Zografos GC.

Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1101-7. doi: 10.1002/pds.1986.

PMID: 20845408

233.

Decreased Hsp90 expression in infiltrative lobular carcinoma: an immunohistochemical study.

Zagouri F, Sergentanis T, Nonni A, Papadimitriou C, Pazaiti A, Michalopoulos NV, Safioleas P, Lazaris A, Theodoropoulos G, Patsouris E, Zografos G.

BMC Cancer. 2010 Aug 6;10:409. doi: 10.1186/1471-2407-10-409.

PMID: 20691061 Free PMC article.

234.

Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions.

Zagouri F, Sergentanis TN, Nonni A, Papadimitriou CA, Michalopoulos NV, Domeyer P, Theodoropoulos G, Lazaris A, Patsouris E, Zogafos E, Pazaiti A, Zografos GC.

BMC Cancer. 2010 Jul 5;10:353. doi: 10.1186/1471-2407-10-353.

PMID: 20602789 Free PMC article.

235.

Prospective evaluation of health-related quality of life in a homogeneous Mediterranean group of colorectal cancer patients.

Theodoropoulos GE, Papailiou JG, Stamopoulos PL, Golemati C, Tsamis D, Zagouri F, Michalopoulos NV, Leandros E.

Am Surg. 2010 May;76(5):502-8. doi: 10.1177/000313481007600518.

PMID: 20506880

236.

Volume of blood suctioned during vacuum-assisted breast biopsy predicts later hematoma formation.

Zagouri F, Sergentanis TN, Domeyer P, Chrysikos D, Giannakopoulou G, Michalopoulos NV, Safioleas P, Flessas I, Panopoulou E, Bletsa G, Zografos GC.

BMC Res Notes. 2010 Mar 12;3:70. doi: 10.1186/1756-0500-3-70.

PMID: 20226029 Free PMC article.

237.

Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends.

Zografos GN, Vasiliadis GK, Zagouri F, Aggeli C, Korkolis D, Vogiaki S, Pagoni MK, Kaltsas G, Piaditis G.

World J Surg Oncol. 2010 Mar 10;8:14. doi: 10.1186/1477-7819-8-14.

PMID: 20219130 Free PMC article.

238.

Ruptured cystadenoma of a duplicated appendix.

Theodoropoulos GE, Tsamis D, Linardoutsos D, Stamopoulos P, Zoumpouli C, Zagouri F, Michalopoulos NV.

Am Surg. 2010 Mar;76(3):341-3.

PMID: 20349673 No abstract available.

239.

Health-related quality of life in vacuum-assisted breast biopsy: short-term effects, long-term effects and predictors.

Domeyer PJ, Sergentanis TN, Zagouri F, Zografos GC.

Health Qual Life Outcomes. 2010 Jan 27;8:11. doi: 10.1186/1477-7525-8-11.

PMID: 20102642 Free PMC article.

240.

Comparison of molecular markers expression in vacuum-assisted biopsies and surgical specimens of human breast carcinomas.

Zagouri F, Sergentanis TN, Nonni A, Papadimitriou CA, Michalopoulos NV, Giannakopoulou G, Bletsa G, Patsouris E, Zografos GC.

Pathol Res Pract. 2010 Jan 15;206(1):30-3. doi: 10.1016/j.prp.2009.08.002.

PMID: 19836148

241.

Acute intermittent porphyria in pregnancy: a common misdiagnosis.

Farfaras A, Zagouri F, Zografos G, Kostopoulou A, Sergentanis TN, Antoniou S.

Clin Exp Obstet Gynecol. 2010;37(4):256-60.

PMID: 21355451 Review.

242.

Lobular breast cancer in men: case report and review of the literature.

Mariolis-Sapsakos T, Theodoropoulos G, Flessas II, Orfanos F, Orfanos N, Konstantinou EA, Zagouri F, Vlachodimitropoulos D, Zografos GC.

Onkologie. 2010;33(12):698-700. doi: 10.1159/000322224. Epub 2010 Nov 26.

PMID: 21124042 Review.

243.

Association between p53 Arg72Pro polymorphism and colorectal cancer risk: a meta-analysis.

Economopoulos KP, Sergentanis TN, Zagouri F, Zografos GC.

Onkologie. 2010;33(12):666-74. doi: 10.1159/000322210. Epub 2010 Nov 26.

PMID: 21124037

244.

Molecular markers in epithelial ovarian cancer: their role in prognosis and therapy.

Zagouri F, Dimopoulos MA, Bournakis E, Papadimitriou CA.

Eur J Gynaecol Oncol. 2010;31(3):268-77.

PMID: 21077467 Review.

245.

Venous thromboembolic events alert for gynecologic neoplasms.

Thomakos N, Papadimitriou CA, Zagouri F, Dimopoulos MA, Antsaklis A.

Onkologie. 2010;33(11):632-6. doi: 10.1159/000321146. Epub 2010 Oct 25.

PMID: 20975312 Review.

246.

Endometrial cancer: what is new in adjuvant and molecularly targeted therapy?

Zagouri F, Bozas G, Kafantari E, Tsiatas M, Nikitas N, Dimopoulos MA, Papadimitriou CA.

Obstet Gynecol Int. 2010;2010:749579. doi: 10.1155/2010/749579. Epub 2010 Feb 2.

PMID: 20148071 Free PMC article.

247.

Breast self-examination and adherence to mammographic follow-up: an intriguing diptych after benign breast biopsy.

Zografos GC, Sergentanis TN, Zagouri F, Papadimitriou CA, Domeyer P, Kontogianni PN, Nonni A, Tsigris C, Patsouris E.

Eur J Cancer Prev. 2010 Jan;19(1):71-2. doi: 10.1097/CEJ.0b013e32832926e8.

PMID: 19901842

248.

Prostate cancer with metastasis to the omentum and massive ascites: a rare manifestation of a common disease.

Zagouri F, Papaefthimiou M, Chalazonitis AN, Antoniou N, Dimopoulos MA, Bamias A.

Onkologie. 2009 Dec;32(12):758-61. doi: 10.1159/000255336. Epub 2009 Nov 20.

PMID: 20016239

249.

Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn’s disease.

Theodoropoulos GE, Linardoutsos D, Tsamis D, Stamopoulos P, Giannopoulos D, Zagouri F, Michalopoulos NV.

World J Gastroenterol. 2009 Nov 7;15(41):5224-7. doi: 10.3748/wjg.15.5224.

PMID: 19891025 Free PMC article.

250.

Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease.

Provatopoulou X, Gounaris A, Kalogera E, Zagouri F, Flessas I, Goussetis E, Nonni A, Papassotiriou I, Zografos G.

BMC Cancer. 2009 Nov 4;9:390. doi: 10.1186/1471-2407-9-390.

PMID: 19889214 Free PMC article.

251.

Biopsy method: a major predictor of adherence after benign breast biopsy?

Sergentanis TN, Zagouri F, Domeyer P, Giannakopoulou G, Tsigris C, Bramis J, Zografos GC.

AJR Am J Roentgenol. 2009 Nov;193(5):W452-7. doi: 10.2214/AJR.08.1061.

PMID: 19843727

252.

Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma.

Roussou M, Tasidou A, Dimopoulos MA, Kastritis E, Migkou M, Christoulas D, Gavriatopoulou M, Zagouri F, Matsouka C, Anagnostou D, Terpos E.

Leukemia. 2009 Nov;23(11):2177-81. doi: 10.1038/leu.2009.130. Epub 2009 Jul 9.

PMID: 19587705 No abstract available.

253.

Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.

Dimopoulos MA, Roussou M, Gavriatopoulou M, Zagouri F, Migkou M, Matsouka C, Barbarousi D, Christoulas D, Primenou E, Grapsa I, Terpos E, Kastritis E.

Clin Lymphoma Myeloma. 2009 Aug;9(4):302-6. doi: 10.3816/CLM.2009.n.059.

PMID: 19717380

254.

Excisional breast biopsy under local anesthesia: stress-related neuroendocrine, metabolic and immune reactions during the procedure.

Zografos GC, Zagouri F, Sergentanis TN, Giannakopoulou G, Provatopoulou X, Kalogera E, Papadimitriou C, Filippakis G, Sagkriotis A, Bramis J, Gounaris A.

In Vivo. 2009 Jul-Aug;23(4):649-52.

PMID: 19567403

255.

Hematoma after vacuum-assisted breast biopsy: are interleukins predictors?

Zografos GC, Zagouri F, Sergentanis TN, Koulocheri D, Flessas I, Provatopoulou X, Kalogera E, Michalopoulos NV, Bramis J, Gounaris A.

Onkologie. 2009 Jul;32(7):395-7. doi: 10.1159/000219366. Epub 2009 Jun 20.

PMID: 19556816

256.

Breast ductal endoscopy: how many procedures qualify?

Zagouri F, Sergentanis TN, Giannakopoulou G, Panopoulou E, Chrysikos D, Bletsa G, Flessas J, Filippakis G, Papalabros A, Bramis KJ, Zografos GC.

BMC Res Notes. 2009 Jun 30;2:115. doi: 10.1186/1756-0500-2-115.

PMID: 19566939 Free PMC article.

257.

Sampling lobular neoplasia of the breast: underestimation despite technical success?

Zagouri F, Sergentanis TN, Nonni A, Papalabros A, Zografos GC.

Virchows Arch. 2009 Jun;454(6):715-6. doi: 10.1007/s00428-009-0773-3. Epub 2009 May 24.

PMID: 19466452 No abstract available.

258.

Ductal endoscopy of the breast: more painful at the luteal phase?

Zografos GC, Zagouri F, Sergentanis TN, Oikonomou V, Fotou M, Nonni A, Patsouris E.

Pain Pract. 2009 May-Jun;9(3):221-4. doi: 10.1111/j.1533-2500.2009.00273.x.

PMID: 19408364

259.

Treatment of early uterine sarcomas: disentangling adjuvant modalities.

Zagouri F, Dimopoulos AM, Fotiou S, Kouloulias V, Papadimitriou CA.

World J Surg Oncol. 2009 Apr 8;7:38. doi: 10.1186/1477-7819-7-38.

PMID: 19356236 Free PMC article. Review.

260.

Diagnosis of papillary lesions in breast biopsy: is conservative management justified?

Zografos GC, Zagouri F, Sergentanis TN, Koulocheri D, Nonni A, Patsouris E.

Am J Surg. 2009 Apr;197(4):550. doi: 10.1016/j.amjsurg.2007.12.055. Epub 2008 Jul 17.

PMID: 18639227 No abstract available.

261.

Spider bite on a male breast: a rare case in the capital.

Zagouri F, Sergentanis TN, Michalopoulos NV, Nonni A, Giannakopoulou G, Zografos GC.

Breast J. 2009 Mar-Apr;15(2):208-9. doi: 10.1111/j.1524-4741.2009.00702.x.

PMID: 19292813 No abstract available.

262.

Management of advanced stage uterine sarcomas: a bone of contention.

Zagouri F, Linardou H, Dimopoulos AM, Papadimitriou CA.

Eur J Gynaecol Oncol. 2009;30(5):483-92.

PMID: 19899397 Review.

263.

Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group.

Papadimitriou CA, Kalofonos H, Zagouri F, Papakostas P, Bozas G, Makatsoris T, Dimopoulos MA, Fountzilas G.

Oncology. 2009;77(3-4):212-6. doi: 10.1159/000236021. Epub 2009 Sep 4.

PMID: 19729979 Clinical Trial.

264.

Early breast cancer diagnosis in Europe, 2007: disastrous exceptions exist.

Zografos GC, Zagouri F, Sergentanis TN, Domeyer PJ, Christopoulos P, Bramis J.

Breast J. 2009 Jan-Feb;15(1):101. doi: 10.1111/j.1524-4741.2008.00677.x.

PMID: 19141136 No abstract available.

265.

Fine-needle aspiration breast biopsy: analysis of pain.

Zografos GC, Zagouri F, Sergentanis TN, Oikonomou V, Fotou M, Patsouris E.

Diagn Cytopathol. 2009 Jan;37(1):74-5. doi: 10.1002/dc.20925.

PMID: 18973132 No abstract available.

266.

Giant cell arteritis of the breast and breast cancer: paraneoplastic manifestation or concomitant disease? A case report.

Kafantari E, Sotiropoulou M, Sfikakis P, Dimitrakakis K, Zagouri F, Mandrekas K, Dimopoulos S, Dimopoulos MA, Papadimitriou CA.

Onkologie. 2008 Dec;31(12):685-8. doi: 10.1159/000165055. Epub 2008 Nov 14.

PMID: 19060507

267.

Diagnosing papillary lesions using vacuum-assisted breast biopsy: should conservative or surgical management follow?

Zografos GC, Zagouri F, Sergentanis TN, Nonni A, Michalopoulos NV, Kontogianni P, Koulocheri D, Dimitriadis IE, Bramis J, Patsouris E.

Onkologie. 2008 Dec;31(12):653-6. doi: 10.1159/000165053. Epub 2008 Nov 20.

PMID: 19060502 Clinical Trial.

268.

Pain during vacuum-assisted breast biopsy: are there any predictors?

Zografos GC, Zagouri F, Sergentanis TN, Nonni A, Domeyer P, Koulocheri D, Flessas I, Panopoulou E, Chrysikos D, Bramis J.

Breast. 2008 Dec;17(6):592-5. doi: 10.1016/j.breast.2008.06.002. Epub 2008 Jul 26.

PMID: 18657974 Clinical Trial.

269.

Convergence between breast flat epithelial atypia and atypical ductal hyperplasia: validity and limitations.

Zografos GC, Zagouri F, Sergentanis TN, Oikonomou V, Nonni A, Patsouris E.

Hum Pathol. 2008 Nov;39(11):1713; author reply 1713-4. doi: 10.1016/j.humpath.2008.07.007. Epub 2008 Aug 29.

PMID: 18760823 No abstract available.

270.

Cores with microcalcifications in DCIS diagnosis: how many cores make the difference?

Zografos GC, Zagouri F, Sergentanis TN, Nonni A, Koulocheri D, Giannakopoulou G, Bramis J.

Eur Radiol. 2008 Nov;18(11):2398. doi: 10.1007/s00330-008-1031-9. Epub 2008 May 24.

PMID: 18500526 No abstract available.

271.

Vacuum-assisted breast biopsy: an easy-to-learn procedure?

Zografos GC, Zagouri F, Sergentanis TN.

Am J Surg. 2008 Nov;196(5):798. doi: 10.1016/j.amjsurg.2007.10.008. Epub 2008 Mar 26.

PMID: 18353275 No abstract available.

272.

Heat shock protein90 in lobular neoplasia of the breast.

Zagouri F, Nonni A, Sergentanis TN, Papadimitriou CA, Michalopoulos NV, Lazaris AC, Patsouris E, Zografos GC.

BMC Cancer. 2008 Oct 28;8:312. doi: 10.1186/1471-2407-8-312.

PMID: 18957107 Free PMC article.

273.

Psychiatric disorder associated with vacuum-assisted breast biopsy clip placement: a case report.

Zografos GC, Zagouri F, Sergentanis TN, Panou M, Dardamanis D, Giannakopoulou G, Filippakis GM, Papadimitriou G, Stamouli S.

J Med Case Rep. 2008 Oct 17;2:332. doi: 10.1186/1752-1947-2-332.

PMID: 18928549 Free PMC article.

274.

Imprint cytology of vacuum-assisted breast biopsy specimens: a rapid diagnostic tool in non-palpable solid lesions.

Oikonomou V, Fotou M, Zagouri F, Sergentanis TN, Nonni A, Athanassiadou P, Drouveli T, Patsouris E, Kotzia E, Zografos GC.

Cytopathology. 2008 Oct;19(5):311-5. doi: 10.1111/j.1365-2303.2007.00513.x. Epub 2007 Oct 22.

PMID: 17953690

275.

Use of fogarty catheter to limit hemorrhage and hematoma after vacuum-assisted breast biopsy.

Zografos GC, Zagouri F, Sergentanis TN, Koulocheri D, Michalopoulos NV, Tsigris C, Bramis J, Gomatos IP.

Acta Radiol. 2008 Sep;49(7):752-4.

PMID: 19143060

276.

Vacuum-assisted breast biopsy in nonpalpable solid breast lesions without microcalcifications: the Greek experience.

Zografos G, Zagouri F, Sergentanis TN, Nonni A, Koulocheri D, Dardamanis D, Oikonomou V, Giannopoulos P, Kouerinis I, Tsigris C, Bramis J.

Diagn Interv Radiol. 2008 Sep;14(3):127-30.

PMID: 18814132

277.

Lesions of “uncertain malignant potential” diagnosed by vacuum-assisted breast biopsy: an unclear management?

Zografos G, Zagouri F, Sergentanis T, Nonni A, Koulocheri D, Patsouris E.

Ann Surg Oncol. 2008 Jul;15(7):2053-4; author reply 2055-6. doi: 10.1245/s10434-008-9834-0. Epub 2008 Apr 19.

PMID: 18425555 No abstract available.

278.

Vacuum-assisted breast biopsy: more cores, more scars?

Zagouri F, Sergentanis TN, Koulocheri D, Zografos GC.

Clin Radiol. 2008 Jun;63(6):736-7. doi: 10.1016/j.crad.2007.11.023. Epub 2008 Mar 11.

PMID: 18455568 No abstract available.

279.

What parameters affect pain in core biopsy?

Zografos GC, Zagouri F, Sergentanis TN, Nonni A, Lymperopoulos N, Patsouris E.

Eur Radiol. 2008 Jun;18(6):1144-5. doi: 10.1007/s00330-008-0879-z. Epub 2008 Feb 16.

PMID: 18278503 Free PMC article. No abstract available.

280.

Vacuum-assisted breast biopsy in close proximity to the skin: a case report.

Zagouri F, Sergentanis TN, Koulocheri D, Giannakopoulou G, Nonni A, Dardamanis D, Michalopoulos NV, Flessas I, Bramis J, Zografos GC.

J Med Case Rep. 2008 May 18;2:165. doi: 10.1186/1752-1947-2-165.

PMID: 18485241 Free PMC article.

281.

Minimizing underestimation rate of microcalcifications excised via vacuum-assisted breast biopsy: a blind study.

Zografos GC, Zagouri F, Sergentanis TN, Nonni A, Koulocheri D, Fotou M, Panopoulou E, Pararas N, Fotiadis C, Bramis J.

Breast Cancer Res Treat. 2008 May;109(2):397-402. doi: 10.1007/s10549-007-9662-0. Epub 2007 Jul 26.

PMID: 17653855 Clinical Trial.

282.

Hematoma after vacuum-assisted breast biopsy: a preventable condition?

Zografos GC, Zagouri F, Sergentanis TN, Nikiteas N, Gomatos IP.

Acta Radiol. 2008 Apr;49(3):277; reply 277. doi: 10.1080/02841850701784552.

PMID: 18365814 No abstract available.

283.

Needle tract seeding after vacuum-assisted breast biopsy.

Michalopoulos NV, Zagouri F, Sergentanis TN, Pararas N, Koulocheri D, Nonni A, Filippakis GM, Chatzipantelis P, Bramis J, Zografos GC.

Acta Radiol. 2008 Apr;49(3):267-70. doi: 10.1080/02841850701775030.

PMID: 18365811

284.

Lobular neoplasia in vacuum-assisted breast biopsy: extended protocols and underestimation.

Zografos GC, Zagouri F, Sergentanis TN.

AJR Am J Roentgenol. 2008 Apr;190(4):W272. doi: 10.2214/AJR.07.3264.

PMID: 18356422 No abstract available.

285.

Lesions too close to the chest wall: a relative contraindication for vacuum-assisted breast biopsy.

Zagouri F, Sergentanis TN, Zografos GC.

AJR Am J Roentgenol. 2008 Apr;190(4):W270. doi: 10.2214/AJR.07.2436.

PMID: 18356420 No abstract available.

286.

Pellet fragments on the mammogram: do not neglect medical history.

Zografos GC, Zagouri F, Sergentanis TN, Domeyer PJ, Koulocheri D, Bramis J.

JBR-BTR. 2008 Mar-Apr;91(2):69.

PMID: 18549159 No abstract available.

287.

Cytokine dysregulation during vacuum-assisted breast biopsy: early phase of a complex phenomenon.

Zografos GC, Zagouri F, Sergentanis TN, Provatopoulou X, Kalogera E, Gounaris A.

Isr Med Assoc J. 2008 Mar;10(3):246.

PMID: 18494247 No abstract available.

288.

Chronic cholecystitis in elderly patients. Correlation of the severity of inflammation with the number and size of the stones.

Domeyer PJ, Sergentanis TN, Zagouri F, Tzilalis B, Mouzakioti E, Parasi A, Nonni A, Mariolis A, Androulakis G, Zografos GC.

In Vivo. 2008 Mar-Apr;22(2):269-72.

PMID: 18468414

289.

Predictors of pain during open breast biopsy under local anesthesia: is there such a thing?

Zografos GC, Zagouri F, Sergentanis TN, Lymperopoulos N, Drikos A, Patsouris E.

Pain Pract. 2008 Mar-Apr;8(2):151. doi: 10.1111/j.1533-2500.2008.00183.x.

PMID: 18366472 Clinical Trial. No abstract available.

290.

Breast ductal endoscopy: do not neglect education.

Zografos GC, Zagouri F, Sergentanis TN.

Onkologie. 2008 Mar;31(3):136. doi: 10.1159/000113931. Epub 2008 Feb 20.

PMID: 18322418 No abstract available.

291.

Vacuum-assisted breast biopsy: could it play a role in sentinel lymph node biopsy?

Zagouri F, Sergentanis TN, Koulocheri D, Zografos GC.

Acta Radiol. 2008 Feb;49(1):25. doi: 10.1080/02841850701675743.

PMID: 18210311 No abstract available.

292.

Atypical ductal hyperplasia: a way to minimize underestimation in vacuum-assisted breast biopsy?

Zografos GC, Zagouri F, Sergentanis TN, Nonni A, Koulocheri D, Bramis J.

Breast. 2008 Feb;17(1):6. doi: 10.1016/j.breast.2007.10.002.

PMID: 18083567 No abstract available.

293.

Pain in different methods of breast biopsy: emphasis on vacuum-assisted breast biopsy.

Zagouri F, Sergentanis TN, Gounaris A, Koulocheri D, Nonni A, Domeyer P, Fotiadis C, Bramis J, Zografos GC.

Breast. 2008 Feb;17(1):71-5. doi: 10.1016/j.breast.2007.07.039. Epub 2007 Sep 14.

PMID: 17869106

294.

[Vacuum-assisted 11 gauge stereotactic macrobiopsy. How to biopsy a small breast?].

Zografos GC, Zagouri F, Sergentanis TN, Giannakopoulou G, Koulocheri D, Al Galaohi M.

J Med Liban. 2008 Jan-Mar;56(1):47.

PMID: 19534092 French. No abstract available.

295.

Evaluation of pain experienced during breast ductal endoscopy.

Zografos GC, Zagouri F, Sergentanis TN, Gounaris A, Pararas N, Oikonomou V, Panopoulou E, Fotiadis C, Bramis J.

Surg Today. 2008;38(10):886-9. doi: 10.1007/s00595-007-3725-z. Epub 2008 Sep 27.

PMID: 18820862

296.

Vacuum-assisted breast biopsy: A role also on palpable lesions?

Zagouri F, Sergentanis TN, Zografos GC.

Med Hypotheses. 2008;70(1):198-9. doi: 10.1016/j.mehy.2007.05.002. Epub 2007 Jun 19.

PMID: 17582694 No abstract available.

297.

Serum interleukin-1 in mastalgia.

Gounaris A, Zagouri F, Sergentanis TN, Provatopoulou X, Kalogera E, Zografos GC.

Pain Pract. 2007 Dec;7(4):372. doi: 10.1111/j.1533-2500.2007.00158.x. Epub 2007 Nov 6.

PMID: 17986158 No abstract available.

298.

Vacuum-assisted breast biopsy: insight into stress-induced endocrine events.

Gounaris A, Zagouri F, Sergentanis TN, Provatopoulou X, Kalogera E, Sagkriotis A, Bramis J, Zografos GC.

In Vivo. 2007 Nov-Dec;21(6):1081-4.

PMID: 18210760

299.

Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia.

Nonni A, Zagouri F, Sergentanis TN, Lazaris AC, Patsouris ES, Zografos GC.

Virchows Arch. 2007 Nov;451(5):893-7. doi: 10.1007/s00428-007-0504-6. Epub 2007 Oct 9.

PMID: 17924141

300.

Secondary breast lymphoma diagnosed by vacuum-assisted breast biopsy: a case report.

Zagouri F, Sergentanis TN, Nonni A, Koulocheri D, Domeyer P, Dardamanis D, Michalopoulos NV, Pararas N, Gounaris A, Zografos GC.

J Med Case Rep. 2007 Oct 23;1:113. doi: 10.1186/1752-1947-1-113.

PMID: 17956632 Free PMC article.

301.

Bilateral synchronous breast carcinomas followed by a metastasis to the gallbladder: a case report.

Zagouri F, Sergentanis TN, Koulocheri D, Nonni A, Bousiotou A, Domeyer P, Michalopoulos NV, Dardamanis D, Konstadoulakis MM, Zografos GC.

World J Surg Oncol. 2007 Sep 11;5:101. doi: 10.1186/1477-7819-5-101.

PMID: 17848197 Free PMC article.

302.

Open breast biopsy under local anesthesia: a well-tolerated method.

Zografos GC, Zagouri F, Sergentanis TN, Gounaris A, Panou M, Bramis J.

Pain Pract. 2007 Sep;7(3):288-9. doi: 10.1111/j.1533-2500.2007.00144.x.

PMID: 17714110 No abstract available.

303.

Pressure palsy mimicking brachial plexus injury after mastectomy.

Zografos GC, Zagouri F, Sergentanis TN, Fotiadis C, Bramis J.

Anaesthesia. 2007 Sep;62(9):968. doi: 10.1111/j.1365-2044.2007.05237.x.

PMID: 17697233 No abstract available.

304.

Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.

Zagouri F, Sergentanis TN, Zografos GC.

World J Surg Oncol. 2007 May 31;5:57. doi: 10.1186/1477-7819-5-57.

PMID: 17540032 Free PMC article. Review.

305.

Is zero underestimation feasible? Extended Vacuum-Assisted Breast Biopsy in solid lesions – a blind study.

Zografos GC, Zagouri F, Sergentanis TN, Koulocheri D, Nonni A, Oikonomou V, Domeyer P, Kotsani M, Fotiadis C, Bramis J.

World J Surg Oncol. 2007 May 14;5:53. doi: 10.1186/1477-7819-5-53.

PMID: 17501997 Free PMC article. Clinical Trial.

306.

Imprint cytology on microcalcifications excised by vacuum-assisted breast biopsy: a rapid preliminary diagnosis.

Fotou M, Oikonomou V, Zagouri F, Sergentanis TN, Nonni A, Athanassiadou P, Drouveli T, Atsouris E, Kotzia E, Zografos GC.

World J Surg Oncol. 2007 Apr 3;5:40. doi: 10.1186/1477-7819-5-40.

PMID: 17407604 Free PMC article.

307.

Vacuum-assisted breast biopsy: the value and limitations of cores with microcalcifications.

Zagouri F, Sergentanis TN, Nonni A, Koulocheri D, Fotou M, Panopoulou E, Panou M, Fotiadis C, Bramis J, Zografos GC.

Pathol Res Pract. 2007;203(8):563-6. doi: 10.1016/j.prp.2007.05.001. Epub 2007 Jul 3.

PMID: 17611039

308.

The effect of nitric oxide synthases inhibitors on inflammatory bowel disease in a rat model.

Pilichos CJ, Kouerinis IA, Zografos GC, Korkolis DP, Preza AA, Gazouli M, Menenakos EI, Loutsidis AE, Zagouri F, Gorgoulis VG, Fotiadis CI.

In Vivo. 2004 Jul-Aug;18(4):513-6.

PMID: 15369194